<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34803415</article-id>
      <article-id pub-id-type="pmc">8598206</article-id>
      <article-id pub-id-type="publisher-id">330986</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S330986</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sleep-Related Hypermotor Epilepsy: Etiology, Electro-Clinical Features, and Therapeutic Strategies</article-title>
        <alt-title alt-title-type="running-authors">Wan et al</alt-title>
        <alt-title alt-title-type="running-title">Wan et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6500-8642</contrib-id>
          <name>
            <surname>Wan</surname>
            <given-names>Huijuan</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref>
          <xref rid="ft0001" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Wang</surname>
            <given-names>Xing</given-names>
          </name>
          <xref rid="aff0004" ref-type="aff">
<sup>4</sup>
</xref>
          <xref rid="ft0001" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Yiyi</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Bin</given-names>
          </name>
          <xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Yangmei</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">
<sup>5</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>Wenhan</given-names>
          </name>
          <xref rid="aff0006" ref-type="aff">
<sup>6</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Kai</given-names>
          </name>
          <xref rid="aff0007" ref-type="aff">
<sup>7</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shao</surname>
            <given-names>Xiaoqiu</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="an0001" ref-type="corresp"/>
        </contrib>
        <aff id="aff0001"><label>1</label><institution>Department of Neurology, Beijing Tiantan Hospital, Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0002"><label>2</label><institution>China National Clinical Research Center for Neurological Diseases (NCRC-ND)</institution>, <addr-line>Beijing</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0003"><label>3</label><institution>Department of Neurology, First Affiliated Hospital, Xiamen University</institution>, <addr-line>Xiamen</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0004"><label>4</label><institution>Department of Neurology, Chongqing University Central Hospital, Chongqing Emergency Medical Centre</institution>, <addr-line>Chongqing</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0005"><label>5</label><institution>Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University</institution>, <addr-line>Chongqing</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0006"><label>6</label><institution>Beijing Neurosurgical Institute, Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0007"><label>7</label><institution>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>People’s Republic of China</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Xiaoqiu Shao <institution>Department of Neurology, Beijing Tiantan Hospital, Capital Medical University</institution>, <addr-line>No. 119 South 4th Ring West Road, Fengtai District</addr-line>, <addr-line>Beijing</addr-line>, <addr-line>100070</addr-line>, <country>People’s Republic of China</country>
<phone>Tel +86-135-5203-4066</phone> Email shaoxiaoqiu2000@aliyun.com</corresp>
        <fn id="ft0001">
          <label>*</label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>11</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>13</volume>
      <fpage>2065</fpage>
      <lpage>2084</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>7</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>10</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2021 Wan et al.</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Wan et al.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref>
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p>Sleep-related hypermotor epilepsy (SHE) is a group of clinical syndromes with heterogeneous etiologies. SHE is difficult to diagnose and treat in the early stages due to its diverse clinical manifestations and difficulties in differentiating from non-epileptic events, which seriously affect patients’ quality of life and social behavior. The overall prognosis for SHE is unsatisfactory, but different etiologies affect patients’ prognoses. Surgical treatment is an effective method for carefully selected patients with refractory SHE; nevertheless, preoperative assessment remains challenging because of the low sensitivity of noninvasive scalp electroencephalogram and imaging to detect abnormalities. However, through a careful analysis of semiology, the clinician can deduce the potential epileptogenic zone. This paper summarizes the research status of the background, etiology, electro-clinical features, diagnostic criteria, prognosis, and treatment of SHE to provide a more in-depth understanding of its pathophysiological mechanism, improve the accuracy in the diagnosis of this group of syndromes, and further explore more targeted therapy plans.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>semiology</kwd>
        <kwd>seizure onset zone</kwd>
        <kwd>SOZ</kwd>
        <kwd>epileptogenic zone</kwd>
        <kwd>hypermotor</kwd>
        <kwd>electroencephalogram</kwd>
      </kwd-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="8"/>
        <ref-count count="151"/>
        <page-count count="20"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s0001">
      <title>Background</title>
      <p>In 1981, Lugaresi and Cirignotta reported five patients with frequent clusters of seizure events during sleep, clinically manifested by bizarre limb movements or dystonic-tonic posturing.<xref rid="cit0001" ref-type="bibr">1</xref> These five patients responded effectively to carbamazepine treatment but not to other antiepileptic drugs, and their interictal and ictal scalp electroencephalogram (EEG) showed no significant abnormalities. Therefore, this syndrome was initially considered a wake-triggered sleep motor disorder and was first described with the term “hypnogenic paroxysmal dystonia” (<xref rid="f0001" ref-type="fig">Figure 1</xref>),” which was later changed to “nocturnal paroxysmal dystonia” (NPD) (<xref rid="f0001" ref-type="fig">Figure 1</xref>).<xref rid="cit0002" ref-type="bibr">2</xref> In the subsequent decades, there have been constant reports of patients with similar clinical manifestations. Nevertheless, whether this syndrome is an epileptic condition is a subject of frequent debate. In 1990, Tinuper et al studied three patients with typical NPD who had frequent seizures during non-rapid eye movement sleep (NREM); two patients had generalized tonic-clonic seizures following typical NPD seizures, and epileptiform discharges in the frontal area were observed on ictal and interictal EEG. Therefore, they concluded that this NPD with a short duration was an epileptic seizure of deep frontal lobe origin, also known as nocturnal frontal lobe epilepsy (NFLE) (<xref rid="f0001" ref-type="fig">Figure 1</xref>).<xref rid="cit0003" ref-type="bibr">3</xref> There has been disagreement about the diagnostic criteria for NFLE and difficulties in differentiating it from non-epileptic condition. A consensus meeting including experts in adult and pediatric epileptology, sleep medicine, and epidemiology was held in Bologna in 2014<xref rid="cit0004" ref-type="bibr">4</xref> to better characterize this disorder’s electro-clinical features and develop more accurate diagnostic criteria. At this meeting, the syndrome was renamed “sleep-related hypermotor epilepsy” (SHE) as a unique syndrome independent of the etiology (genetic, structural, or both) and the brain regions involved (<xref rid="f0001" ref-type="fig">Figure 1</xref>). The following consensus were reached: (1) seizures are predominantly experienced during sleep rather than at night, and (2) seizures can originate not only in the frontal lobe but also outside the frontal lobe, and there is no significant difference in epileptic semiology characteristics.<fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p>Historical background of sleep-related hypermotor epilepsy.</p></caption><graphic xlink:href="NSS-13-2065-g0001" content-type="print-only" position="float"/><attrib><bold>Abbreviations</bold>: HPD, hypnogenic paroxysmal dystonia; NPD, nocturnal paroxysmal dystonia; NFLE, nocturnal frontal lobe epilepsy; SHE, sleep-related hypermotor epilepsy.</attrib></fig></p>
    </sec>
    <sec id="s0002">
      <title>Etiology of SHE</title>
      <p>Most SHE cases are sporadic, with no clear etiology. The main known etiologies include genetic and structural etiologies. Structural abnormalities include focal cortical dysplasia (FCD) and acquired injuries. In terms of clinical presentation, there is no significant difference between sporadic and familial cases, that is, autosomal dominant sleep-related hypermotor epilepsy (ADSHE).<xref rid="cit0004" ref-type="bibr">4</xref></p>
      <sec id="s0002-s2001">
        <title>Structural Etiology</title>
        <p>FCD is the most common pathological manifestation in patients with surgically treated drug-resistant SHE, especially FCD type II.<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0006" ref-type="bibr">6</xref> Previous studies have also shown that FCD, particularly small FCD type II, frequently leads to sleep-related epileptic seizures.<xref rid="cit0007" ref-type="bibr">7</xref> Abnormal neuronal architecture within the FCD leads to abnormal synaptic connections and neurotransmitter systems, resulting in enhanced local epileptogenicity and the generation of various abnormal electrical activities. Nobili et al hypothesized that the sleep-related seizures seen in patients with FCD might be due to the specific electrical activity exhibited by the dysplastic cortex, that is, short bursts of fast discharge that can be suppressed by activity during wakefulness and are usually more sporadic during wakefulness but increase in frequency during slow-wave sleep and can be periodic. This characteristic low-amplitude fast activity has also been observed in non-lesion areas around the FCD during slow-wave sleep.<xref rid="cit0008" ref-type="bibr">8</xref> In surgically treated patients with SHE, FCD, developmental tumors (eg, dysembryoplastic neuroepithelial tumor), brain trauma, and ganglioglioma have also been reported.<xref rid="cit0005" ref-type="bibr">5</xref></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Genetic Etiology</title>
        <p>SHE includes sporadic and familial forms, with approximately 86% of cases being sporadic and 14% being familial.<xref rid="cit0009" ref-type="bibr">9</xref> Although the etiology is unknown in the vast majority of patients, a small number of sporadic cases and approximately 30% of patients with familial SHE are associated with genetic mutations.<xref rid="cit0009" ref-type="bibr">9</xref>,<xref rid="cit0010" ref-type="bibr">10</xref> As a genetic heterogeneity syndrome, the severity of epileptic seizures in SHE families varies greatly and may be related to mutations in different genes.<xref rid="cit0009" ref-type="bibr">9</xref> We summarize the major genes that have been reported in <xref rid="t0001" ref-type="table">Table 1</xref>.<table-wrap position="float" id="t0001"><label>Table 1</label><caption><p>Pathogenic and Likely Pathogenic Variants in SHE-Associated Genes</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">c.DNA Nucleotidic Change</th><th rowspan="1" colspan="1">Protein Aminoacidic Change</th><th rowspan="1" colspan="1">Mutation Type</th><th rowspan="1" colspan="1">Inheritance</th><th rowspan="1" colspan="1">Frequency of Pathogenic Variants</th><th rowspan="1" colspan="1">Function Effects</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold><italic toggle="yes">CHRNA4</italic></bold><xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0017" ref-type="bibr">17</xref></td><td rowspan="1" colspan="1">c.851C&gt;T</td><td rowspan="1" colspan="1">p.Ser284Leu</td><td rowspan="1" colspan="1">Missense</td><td rowspan="7" colspan="1">Autosomal dominant (ADSHE)</td><td rowspan="3" colspan="1">2.9%</td><td rowspan="7" colspan="1">Increased sensitivity to ACh</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">c.851C&gt;G</td><td rowspan="1" colspan="1">p.Ser284Trp</td><td rowspan="1" colspan="1">Missense</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">c.920G&gt;T</td><td rowspan="1" colspan="1">p.Gly307Val</td><td rowspan="1" colspan="1">Missense</td></tr><tr><td rowspan="2" colspan="1"><bold><italic toggle="yes">CHRNB2</italic></bold><xref rid="cit0018" ref-type="bibr">18–20</xref></td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">V287L</td><td rowspan="2" colspan="1">Missense</td><td rowspan="2" colspan="1">Rare</td></tr><tr><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">V287M</td></tr><tr><td rowspan="2" colspan="1"><bold><italic toggle="yes">CHRNA2</italic></bold><xref rid="cit0021" ref-type="bibr">21</xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ile279Asn</td><td rowspan="1" colspan="1">Non-synonymous substitution</td><td rowspan="2" colspan="1">Rare</td></tr><tr><td rowspan="1" colspan="1">c.754T&gt;C</td><td rowspan="1" colspan="1">p.Tyr252His</td><td rowspan="1" colspan="1">Missense</td></tr><tr><td rowspan="6" colspan="1"><bold><italic toggle="yes">KCNT1</italic></bold><xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0023" ref-type="bibr">23</xref>,<xref rid="cit0026" ref-type="bibr">26</xref></td><td rowspan="1" colspan="1">c.2800G&gt;A</td><td rowspan="1" colspan="1">p.Ala934Thr</td><td rowspan="6" colspan="1">Missense</td><td rowspan="6" colspan="1">De novo</td><td rowspan="6" colspan="1">1%</td><td rowspan="6" colspan="1">Domain allosterically regulate channel opening and potassium ion permeation</td></tr><tr><td rowspan="1" colspan="1">c.1193G&gt;A</td><td rowspan="1" colspan="1">p.Arg398Gln</td></tr><tr><td rowspan="1" colspan="1">c.2386T&gt;C;</td><td rowspan="1" colspan="1">p.Tyr796His</td></tr><tr><td rowspan="1" colspan="1">c.2782C&gt;T;</td><td rowspan="1" colspan="1">p.Arg928Cys</td></tr><tr><td rowspan="1" colspan="1">c.2688G&gt;A;</td><td rowspan="1" colspan="1">p.Met896Ile</td></tr><tr><td rowspan="1" colspan="1">c.862G&gt;A</td><td rowspan="1" colspan="1">p.Gly288Ser</td></tr><tr><td rowspan="1" colspan="1"><bold><italic toggle="yes">DEPDC5</italic></bold><xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0033" ref-type="bibr">33</xref>,<xref rid="cit0034" ref-type="bibr">34</xref></td><td rowspan="1" colspan="1">c.1165dupC</td><td rowspan="1" colspan="1">p.Arg389Profs*2</td><td rowspan="1" colspan="1">Frameshift</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="4" colspan="1">3.9% the highest</td><td rowspan="4" colspan="1">Loss of inhibition of the mTOR pathway, resulting in overproliferation. Warning of FCDs</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">c.1264C&gt;T</td><td rowspan="1" colspan="1">p.Arg422*</td><td rowspan="1" colspan="1">Nonsense</td><td rowspan="1" colspan="1">Paternal</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">c.193+1G&gt;A</td><td rowspan="1" colspan="1">p.(?)</td><td rowspan="1" colspan="1">Canonical splice- site variant</td><td rowspan="1" colspan="1">Maternal</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">c.1225delA</td><td rowspan="1" colspan="1">p.Thr409Hisfs*15</td><td rowspan="1" colspan="1">Frameshift</td><td rowspan="1" colspan="1">Unknown</td></tr><tr><td rowspan="2" colspan="1"><bold><italic toggle="yes">NPRL2</italic></bold><xref rid="cit0035" ref-type="bibr">35</xref></td><td rowspan="1" colspan="1">c.314T&gt;C</td><td rowspan="1" colspan="1">p.Leu105Pro</td><td rowspan="2" colspan="1">Missense</td><td rowspan="2" colspan="1">Maternal</td><td rowspan="2" colspan="1">1%</td><td rowspan="3" colspan="1">Changing the GATOR1 protein complex, thus affecting the mTOR-signaling pathway</td></tr><tr><td rowspan="1" colspan="1">c.100 C&gt;T</td><td rowspan="1" colspan="1">p.Arg34*</td></tr><tr><td rowspan="1" colspan="1"><bold><italic toggle="yes">NPRL3</italic></bold><xref rid="cit0035" ref-type="bibr">35</xref></td><td rowspan="1" colspan="1">c.835_836insT</td><td rowspan="1" colspan="1">p.Ser279Phe fs*52</td><td rowspan="1" colspan="1">Frameshift</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1"><bold><italic toggle="yes">CRH</italic></bold><xref rid="cit0037" ref-type="bibr">37<bold>–</bold>39</xref></td><td rowspan="1" colspan="1">c. 89C&gt;G</td><td rowspan="1" colspan="1">p.Pro30Arg</td><td rowspan="1" colspan="1">Missense</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alter the ability of the cell to promptly produce, process and secrete the mature hormone</td></tr><tr><td rowspan="1" colspan="1"><bold><italic toggle="yes">PRIMA1</italic></bold><xref rid="cit0010" ref-type="bibr">10</xref>,<xref rid="cit0040" ref-type="bibr">40</xref></td><td rowspan="1" colspan="1">c.93+2T&gt;C</td><td rowspan="1" colspan="1">knockout of PRIMA1.</td><td rowspan="1" colspan="1">Splice site</td><td rowspan="1" colspan="1">Autosomal recessive (ARSHE)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">Enhanced cholinergic responses</td></tr><tr><td rowspan="1" colspan="1"><bold><italic toggle="yes">STX1B</italic></bold><xref rid="cit0042" ref-type="bibr">42</xref></td><td rowspan="1" colspan="1">C.106–2A&gt;G</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">Aberrant splicing/mRNA decay</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold><italic toggle="yes">CABP4</italic></bold><xref rid="cit0041" ref-type="bibr">41</xref></td><td rowspan="1" colspan="1">c.464G&gt;A</td><td rowspan="1" colspan="1">p.G155D</td><td rowspan="1" colspan="1">Missense</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">Decreases ion channel activation, leading to reduced Ca2+ concentrations</td></tr><tr><td rowspan="1" colspan="1"><bold><italic toggle="yes">PPT1</italic></bold><xref rid="cit0042" ref-type="bibr">42</xref></td><td rowspan="1" colspan="1">c.433G&gt;C</td><td rowspan="1" colspan="1">p.G145R</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">Autosomal recessive (ARSHE)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">Neuronal ceroid lipofuscinosis</td></tr><tr><td rowspan="1" colspan="1"><bold><italic toggle="yes">Tsc1</italic></bold><xref rid="cit0043" ref-type="bibr">43</xref></td><td rowspan="1" colspan="1">c.843del</td><td rowspan="1" colspan="1">p.Ser282Glnfs*36</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(mTOR) cascade dysfunction</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Notes:</bold> Modyfied with permission from Licchetta L, Pippucci T, Baldassari S, et al. Sleep-related hypermo-tor epilepsy (SHE): contribution of known genes in 103 patients. <italic toggle="yes">Seizure</italic>. 2020;74:60–64. Copyright 2020, with permission from Elsevier.<xref rid="cit0016" ref-type="bibr">16</xref></p></fn><fn><p><bold>Abbreviations</bold>: SHE, sleep-related hypermotor epilepsy; ADSHE, autosomal dominant sleep-related hypermotor epilepsy; ARSHE, autosomal recessive sleep-related hypermotor epilepsy; Ach, acetylcholine; <italic toggle="yes">DEPDC5</italic>, pleckstrin domain-containing protein 5; <italic toggle="yes">NPRL</italic>, nitrogen permease regulator-like; GATOR1, gap activity toward rags 1; mTOR, mammalian target of rapamycin; FCD, focal cortical dysplasia; CRH, corticotropin-releasing hormone.</p></fn></table-wrap-foot></table-wrap>
</p>
        <p>In 1995, Steinlein et al reported a missense mutation in <italic toggle="yes">CHRNA4</italic>, which encodes the α4 subunit of the nicotinic acetylcholine receptor (nAChR) in a family of 21 patients with ADSHE and four carriers.<xref rid="cit0011" ref-type="bibr">11</xref> Since then, mutations in other genes, such as <italic toggle="yes">CHRNA2</italic> and <italic toggle="yes">CHRNB2</italic>, have been reported.<xref rid="cit0012" ref-type="bibr">12</xref>,<xref rid="cit0013" ref-type="bibr">13</xref> nAChRs are widely distributed in the brain and contribute to the regulation of sleep-wake oscillations at the cortical and subcortical levels.<xref rid="cit0014" ref-type="bibr">14</xref> However, the function of nAChRs is altered after mutations in the genes, resulting in increased sensitivity to ACh, activation of the ascending cholinergic pathway in the brainstem, and enhanced GABAergic function,<xref rid="cit0015" ref-type="bibr">15</xref> thus creating conditions for sleep instability and the generation of epileptic seizures. Up to now, the pathogenic and likely pathogenic variants in <italic toggle="yes">CHRNA4</italic> that have been identified include p.Ser284Leu, p.Ser284Trp, and p.Gly307Val,<xref rid="cit0016" ref-type="bibr">16</xref> which have been summarized in <xref rid="t0001" ref-type="table">Table 1</xref>. The table does not include the p.Ser252Leu and p.Thr26Met mutations, as well as two missense variants on the same allele of the CHRNA4 gene: c.742A&gt;T (Ile248Phe) and c.1708G&gt;C(Gly570Arg),<xref rid="cit0017" ref-type="bibr">17</xref> whose variants were anecdotally implicated in inherited forms of SHE, but not confirmed in other cases. Previous studies have identified V287L and V287M mutations in the <italic toggle="yes">CHRNB2</italic> gene, coding for the β2 subunit of the nAChR.<xref rid="cit0018" ref-type="bibr">18</xref>,<xref rid="cit0019" ref-type="bibr">19</xref> Both mutations involve the same residue, located, as the <italic toggle="yes">CHRNA4</italic> mutations, that cause nAChR functionality to change.<xref rid="cit0018" ref-type="bibr">18–20</xref> Similarly, the mutation on <italic toggle="yes">CHRNA2</italic>, resulting in the non-synonymous substitution Ile279Asn, also increases the nAChR sensitivity, as observed in several ADSHE-linked mutations of the onα4 and β2 subunits.<xref rid="cit0021" ref-type="bibr">21</xref> However, these mutations in <italic toggle="yes">CHRNB2</italic> and <italic toggle="yes">CHRNA2</italic> are rare in patients with ADSHE.<xref rid="cit0018" ref-type="bibr">18</xref>,<xref rid="cit0019" ref-type="bibr">19</xref>,<xref rid="cit0021" ref-type="bibr">21</xref></p>
        <p>Mutations in the <italic toggle="yes">KCNT1</italic> gene encoding subunit 1 of the sodium-activated potassium channel have been identified in some patients with ADSHE and comorbid psychiatric, behavioral, and intellectual disorders.<xref rid="cit0022" ref-type="bibr">22</xref> The pathogenic mechanism of <italic toggle="yes">KCNT1</italic> mutations may be the increased firing frequency of pyramidal neurons and attenuation of the inhibition of interneuron excitability, leading to network de-inhibition and epileptic seizures.<xref rid="cit0023" ref-type="bibr">23</xref>,<xref rid="cit0024" ref-type="bibr">24</xref> Previous studies have suggested that mutations in <italic toggle="yes">KCNT1</italic> are associated with non-lesional SHE. In a recent study, four patients with SHE were reported to have mild malformations of cortical development (mMCD) and <italic toggle="yes">KCNT1</italic> mutations. Three unrelated patients with magnetic resonance imaging (MRI)-negative results received a neuropathological diagnosis of FCD type I after epilepsy surgery, and one case of periventricular nodular heterotopia was detected by MRI. Studies have suggested that <italic toggle="yes">KCNT1</italic> mutations are epileptogenic not only because of excitability dysregulation due to the role of this gene in controlling sodium-potassium transport but also possibly due to mMCD. Thus, epilepsy caused by pathogenic variants of <italic toggle="yes">KCNT1</italic> may include both lesional and non-lesional epilepsy.<xref rid="cit0025" ref-type="bibr">25</xref> We listed SHE-related pathogenic mutations of <italic toggle="yes">KCNT1</italic> in <xref rid="t0001" ref-type="table">Table 1</xref>; however, it should be noted that even in members of the same family, the same <italic toggle="yes">KCNT1</italic> mutation can either cause SHE or malignant migrating focal seizures of infancy.<xref rid="cit0023" ref-type="bibr">23</xref>,<xref rid="cit0026" ref-type="bibr">26</xref></p>
        <p>In addition, loss-of-function (LOF) mutations in the pleckstrin (DEP) domain-containing 5 (<italic toggle="yes">DEPDC5</italic>) gene have been identified in some ADSHE-affected families, and patients with <italic toggle="yes">DEPDC5</italic> mutations have shown a high rate of drug resistance.<xref rid="cit0027" ref-type="bibr">27</xref>
<italic toggle="yes">DEPDC5</italic> was previously thought to be associated with familial focal epilepsy with variable foci.<xref rid="cit0028" ref-type="bibr">28</xref> The mechanistic target of rapamycin (mTOR) protein has serine-threonine kinase activity; it phosphorylates several downstream proteins and regulates cell growth, proliferation, and migration.<xref rid="cit0029" ref-type="bibr">29</xref> GTPase-activating protein activity toward the Ras-related GTPases (GATOR) complex 1 (GATOR1) is upstream of the mTOR pathway and negatively regulates mTOR complex 1 (mTORC1).<xref rid="cit0030" ref-type="bibr">30</xref>,<xref rid="cit0031" ref-type="bibr">31</xref> The GATOR1 complex consists of three proteins: <italic toggle="yes">DEPDC5</italic>, nitrogen permease regulator-like 2 (<italic toggle="yes">NRPL2</italic>), and nitrogen permease regulator-like 3 (<italic toggle="yes">NRPL3</italic>). Thus, LOF mutations in the <italic toggle="yes">DEPDC5</italic> gene can lead to loss of inhibition of the mTOR pathway, resulting in overproliferation, which leads to irregular growth of the lesion, anatomical disruption of the neural circuit, and consequently epilepsy. The mTOR pathway is involved in the pathogenesis of brain malformations.<xref rid="cit0032" ref-type="bibr">32</xref></p>
        <p><italic toggle="yes">DEPDC5</italic> shows the highest mutation frequency, especially in cases with a structural etiology.<xref rid="cit0016" ref-type="bibr">16</xref> Thus, analysis of this gene is recommended even in isolated cases. The <italic toggle="yes">DEPDC5</italic> variants identified include four LOF variants, namely, p.Arg389Profs*2, p.Arg422*c.193+1G&gt;A, and p.Thr409Hisfs*15.<xref rid="cit0033" ref-type="bibr">33</xref>,<xref rid="cit0034" ref-type="bibr">34</xref> Furthermore, variants of the genes encoding <italic toggle="yes">NPRL2</italic> and <italic toggle="yes">NPRL3</italic> were also confirmed, but whether these mutations are pathogenic and their role in the pathogenesis of SHE still needs to be confirmed in further studies.<xref rid="cit0033" ref-type="bibr">33–35</xref></p>
        <p>In addition to the aforementioned mutations, an Italian ADSHE family line study revealed a mutation in the CRH gene.<xref rid="cit0036" ref-type="bibr">36</xref> In 2013, Sansoni et al reported a novel mutation (p.Pro30Arg) within the CRH gene cosegregating with ADSHE d detected in an Italian family. The resulting amino acid change in CRH was predicted to be pathogenic (PolyPhen-2).<xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0038" ref-type="bibr">38</xref> The mutation appears to alter the ability of the cell to promptly produce, process, and secrete the mature hormone, but the direct role of the p.Pro30Arg in the pathogenesis of SHE remains unclear.<xref rid="cit0037" ref-type="bibr">37</xref> Mutation of the CRH gene has been confirmed in patients with ADSHE, and variations in the CRH gene detected in patients with SHE lead to altered hormone levels, suggesting that individuals with such hormonal alterations may be more susceptible to the disease.<xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0039" ref-type="bibr">39</xref></p>
        <p>In 2015, Hildebrand et al reported a newly identified autosomal recessive pathogenic gene, the <italic toggle="yes">PRIMA1</italic> gene of chromosome 14 in the splicing site (C.93+2T&gt;C), wherein a homozygous mutation led to the skipping of the first coding exon of <italic toggle="yes">PRIMA1</italic> mRNA and the deletion of the <italic toggle="yes">PRIMA1</italic> gene. <italic toggle="yes">PRIMA1</italic> is a transmembrane protein that anchors acetylcholinesterase (AChE) to the membrane of neurons. Reduction of this gene leads to decreased AChE, accumulation of acetylcholine and mutation of functional effects of acetylcholine receptor subunits, leading to SHE. Enhanced cholinergic response may be responsible for severe intellectual disability in this family. This is the first reported case of a recessive mutation of <italic toggle="yes">PRIMA1</italic> associated with the disease but has not been confirmed in other cases.<xref rid="cit0040" ref-type="bibr">40</xref></p>
        <p>Chen et al performed whole-exome sequencing in four typical patients selected from a family line with seven patients. They identified the <italic toggle="yes">CABP4</italic> gene, encoding calcium-binding protein 4, as a possible new pathogenic gene for ADSHE.<xref rid="cit0041" ref-type="bibr">41</xref> Mutation of this gene mainly affects the calcium channel, leading to abnormal distribution of calcium ions inside and outside the cell, thereby inducing seizures.<xref rid="cit0041" ref-type="bibr">41</xref> The <italic toggle="yes">STX1B</italic> gene encodes syntaxin-1B, which is involved in the release of glutamate and GABA. Mutations in this gene may disrupt the inherent splicing receptor site, leading to abnormal splicing and resulting in abnormal proteins or mRNA decay. <italic toggle="yes">STX1B</italic> gene mutation may be related to the SHE phenotype and autonomic dysfunction, characterized by peri-ictal hypotension, and testing for this gene should be considered in such patients.<xref rid="cit0042" ref-type="bibr">42</xref> In this study, a variant of unknown significance was also detected in the <italic toggle="yes">PPT1</italic> gene (encoding palmitoyl protein thioesterase 1), but whether it plays a role in SHE needs further experimental verification.<xref rid="cit0042" ref-type="bibr">42</xref> A case report suggests that SHE may also be associated with mutations in the <italic toggle="yes">TSC1</italic> gene, which plays a pathogenic role in SHE through the (mTOR) pathway.<xref rid="cit0043" ref-type="bibr">43</xref> Recent studies in epileptic brain tissues have suggested that defective expression of circadian locomotor output cycles kaput (CLOCK), a transcription factor that regulates the circadian rhythm and mTOR pathway, may be responsible for the predisposition of epileptic seizures during sleep.<xref rid="cit0044" ref-type="bibr">44</xref></p>
        <p>The genetic and structural etiologies of SHE are not mutually exclusive. In particular, patients with refractory epilepsy with mutations in GATOR1-related genes combined with cortical developmental malformations can benefit from surgery. Therefore, patients with hereditary SHE are not an absolute contraindication for surgery.</p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Electro-Clinical Features of SHE</title>
      <sec id="s0003-s2001">
        <title>Clinical Features</title>
        <p>SHE is relatively rare, with a large retrospective population-based cohort study showing its prevalence at approximately 1.8/100,000.<xref rid="cit0045" ref-type="bibr">45</xref> According to previous reports, most patients had disease onset before the age of 20 years,<xref rid="cit0007" ref-type="bibr">7</xref>,<xref rid="cit0008" ref-type="bibr">8</xref> with a predominance in childhood and adolescence,<xref rid="cit0046" ref-type="bibr">46</xref> although seizures originating in adulthood have also been reported.<xref rid="cit0047" ref-type="bibr">47</xref> Epileptic seizures occur mainly during sleep, mostly during NREM sleep, rarely during rapid eye movement sleep, and occasionally during wakefulness.<xref rid="cit0003" ref-type="bibr">3</xref> Seizure frequency may be very high, with episodes occurring every or almost every night, usually multiple episodes per night.<xref rid="cit0007" ref-type="bibr">7</xref> “Clusters of seizures” are a diagnostic feature but not required. As most seizures occur during sleep, sleep disruption can lead to daytime sleepiness in patients.<xref rid="cit0048" ref-type="bibr">48</xref></p>
        <p>The primary forms of seizures are brief (less than 2 min), individualized and stereotyped hypermotor seizures<xref rid="cit0004" ref-type="bibr">4</xref> with sudden onset and offset.<xref rid="cit0006" ref-type="bibr">6</xref>,<xref rid="cit0009" ref-type="bibr">9</xref>,<xref rid="cit0049" ref-type="bibr">49</xref> The clinical features are vigorous hypermotor movements (eg, hypermotor proximal joint or trunk movements, such as limb kicking, arm flinging, and body rocking),<xref rid="cit0006" ref-type="bibr">6</xref>,<xref rid="cit0050" ref-type="bibr">50</xref> usually accompanied by vocalization, emotional facial expressions, and vegetative symptoms.<xref rid="cit0050" ref-type="bibr">50</xref>,<xref rid="cit0051" ref-type="bibr">51</xref> Asymmetric dystonic/tonic posturing with or without head/eye deviation can also be observed in patients with SHE.<xref rid="cit0046" ref-type="bibr">46</xref>,<xref rid="cit0052" ref-type="bibr">52</xref></p>
        <p>In addition, patients with SHE often experience paroxysmal arousals (PAs) and minor motor events (MMEs). PAs are characterized by sudden and brief awakenings (lasting 5–10 s), sometimes accompanied by stereotyped movements, vocalizations, nervous expressions, and fearfulness.<xref rid="cit0006" ref-type="bibr">6</xref>,<xref rid="cit0046" ref-type="bibr">46</xref> Stereotyped movements may manifest as sudden movements of the trunk and upper limbs, with the patient appearing awake but unconscious and falling asleep soon after the episode. MMEs are characterized by brief (lasting 2–4 s), stereotyped movements involving the axial musculature, limbs, and/or head.<xref rid="cit0046" ref-type="bibr">46</xref>,<xref rid="cit0053" ref-type="bibr">53</xref> In stereoelectroencephalography (SEEG) recordings, PAs are always closely associated with epileptiform discharges.<xref rid="cit0054" ref-type="bibr">54–56</xref> However, it is difficult to ascertain whether the MMEs should be regarded as an epilepsy event.<xref rid="cit0054" ref-type="bibr">54</xref>,<xref rid="cit0057" ref-type="bibr">57</xref>,<xref rid="cit0058" ref-type="bibr">58</xref> By analyzing SEEG recordings in patients with SHE, Terzaghi et al found that more than two-thirds of MMEs were related to epileptiform discharges, and the variable expression of MMEs could not be attributed to the presence of epileptiform discharges.<xref rid="cit0053" ref-type="bibr">53</xref> Current opinion considers that MMEs are probably not true epileptic manifestations but rather are motor manifestations with relation to sleep instability.<xref rid="cit0056" ref-type="bibr">56</xref> Occasionally, patients will get out of bed and run around repetitively. These movements are called epileptic nocturnal wanderings, which are difficult to distinguish from sleepwalking.<xref rid="cit0046" ref-type="bibr">46</xref> A video polysomnography (VPSG) study of 100 NFLE cases found that sleep-associated seizure events of varying intensity (from PAs to nocturnal wanderings) and duration may occur in a single night in a given patient.<xref rid="cit0046" ref-type="bibr">46</xref></p>
        <p>SHE seizures vary in complexity, ranging from sudden arousal or mild motor events<xref rid="cit0046" ref-type="bibr">46</xref>,<xref rid="cit0059" ref-type="bibr">59</xref> to hypermotor seizures, and multiple seizure forms can be present in combinations in a single patient, even during a single night. This may be due to differences in the discharge duration within the frontal lobe and the pathways that propagate within the brain.<xref rid="cit0059" ref-type="bibr">59</xref>,<xref rid="cit0060" ref-type="bibr">60</xref> As highlighted in the 2014 consensus conference,<xref rid="cit0004" ref-type="bibr">4</xref> SHE does not solely originate in the frontal lobes, and seizures initiated outside the frontal lobes may also trigger hypermotor seizures or dystonic-tonic postural seizures. A SEEG study in patients with drug-resistant SHE confirmed that up to 30% of seizures were of extrafrontal origin.<xref rid="cit0061" ref-type="bibr">61</xref> The extrafrontal epileptogenic zone (EZ) reported in several studies also includes the temporal and parietal lobes and the insula.<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0056" ref-type="bibr">56</xref>,<xref rid="cit0062" ref-type="bibr">62–66</xref> The clinical features of SHE of the frontal and extrafrontal origins are very similar. Regardless of the origin, hypermotor seizures and complex behavior occur when ictal discharges are transmitted to structures such as the cingulate, frontal, and parietal cortices.<xref rid="cit0052" ref-type="bibr">52</xref></p>
        <p>Increasing number of studies have reported that some patients with SHE have cognitive deficits and behavioral and mental problems.<xref rid="cit0026" ref-type="bibr">26</xref>,<xref rid="cit0067" ref-type="bibr">67–70</xref> Studies have also reported that SHE has negative effects on patients’ neuropsychology, with 53.3% of patients presenting with neuropsychological defects and 15% diagnosed with intellectual disabilities.<xref rid="cit0071" ref-type="bibr">71</xref> The cognitive impairment was more significant in verbal IQ and extrafrontal and selective frontal functions.<xref rid="cit0071" ref-type="bibr">71</xref> Furthermore, variables of clinical severity (ie, high seizure frequency, status epilepticus, and bilateral convulsive seizures, poor response to antiepileptic treatment) were negatively correlated with memory and executive functions.<xref rid="cit0071" ref-type="bibr">71</xref></p>
        <p>In addition to the variables of clinical severity mentioned above, it is currently believed that cognitive impairment is also related to the following factors: 1. Genetic and structural etiologies. Previous studies have shown that patients with SHE with genetic mutations have lower IQ scores than those who have do not these mutations, irrespective of the specific gene.<xref rid="cit0048" ref-type="bibr">48</xref> Simultaneously, we also believe that the neuropsychological damage caused by different gene mutations may have different underlying mechanisms,<xref rid="cit0071" ref-type="bibr">71</xref> which is corroborated by some clinical and basic studies, for example, <italic toggle="yes">KCNT1</italic> mutations appear to be associated with more severe intellectual impairment and psychiatric symptoms;<xref rid="cit0004" ref-type="bibr">4</xref>
<italic toggle="yes">GATOR1</italic> expression related gene mutations are associated with early-onset of epilepsy, cognitive decline, and sudden death in patients with epilepsy, and approximately 20% of patients may be associated with cortical dysplasia,<xref rid="cit0072" ref-type="bibr">72</xref> whereas several studies have described mutations in the genes coding for nAChR subunits (eg, <italic toggle="yes">CHRNA4, CHRNA2</italic>, and <italic toggle="yes">CHRNB2</italic>) with particular emphasis on the impact on frontal lobe functions. Animal studies have also shown that S284L-mutation in <italic toggle="yes">CHRNA4</italic> caused several important functional associations with ADSHE and its comorbidity of cognitive deficits.<xref rid="cit0073" ref-type="bibr">73–76</xref> However, more studies are needed to further investigate the genotype-clinical correlation and their underlying mechanisms in patients with SHE. 2. Sleep fragmentation. Most patients with SHE experience frequent seizures, especially during sleep, thus frequent seizures disrupt sleep architecture. It is well known that sleep is crucial to learning and memory. Sleep reactivates neuronal learning activities, allowing the reprocessing of memories during both NREM and REM sleep, which interact during memory consolidation.<xref rid="cit0077" ref-type="bibr">77</xref> The disruption of sleep quality caused by epilepsy (including shorter total sleep time, poorer sleep efficiency, and prolonged sleep latency) may impair executive function and memory.<xref rid="cit0078" ref-type="bibr">78</xref> 3. The onset age. Animal model studies have suggested that the cause of cognitive dysfunction due to early-onset epilepsy could be damage to neural regeneration and the reorganization of synapses, resulting in the absence of dendritic spines in hippocampal pyramidal neurons,<xref rid="cit0079" ref-type="bibr">79</xref> thus raising the question whether there is a possibility that the younger the age of onset of SHE, the more severe the cognitive impairment will be and what the underlying mechanism; these need to be investigated in future studies.</p>
      </sec>
      <sec id="s0003-s2002">
        <title>Seizure Semiology and Anatomoclinical Correlation</title>
        <p>Seizure semiology refers to the physical signs and symptoms of seizures dependent on the epileptic network involved in the seizure, that is, the EZ and its propagation networks.<xref rid="cit0080" ref-type="bibr">80</xref> Epileptic seizures can involve multiple sites sequentially and may combine multiple seizure types with a relatively fixed order of evolution.<xref rid="cit0081" ref-type="bibr">81</xref> Epilepsies originating in a particular brain region often have a relatively characteristic clinical semiology.<xref rid="cit0082" ref-type="bibr">82</xref> Careful generalization and search for this evidence can provide a more accurate understanding of the seizure origin and epileptic network. In the last decade, with the rapid development of SEEG, the electro-clinical features of focal epilepsy and its relationship with functional anatomy have become clearer in combination with semiology and structural and functional imaging, and anatomical-electrical-clinical data provide adequate evidence to locate the sites of origin of SHE and the epileptic networks. Although semiology is subjective in nature<xref rid="cit0082" ref-type="bibr">82</xref> and the symptomatogenic zone is not equivalent to the EZ or seizure onset zone (SOZ),<xref rid="cit0083" ref-type="bibr">83</xref>,<xref rid="cit0084" ref-type="bibr">84</xref> there is a strong connection between the EZ and early propagation networks;<xref rid="cit0081" ref-type="bibr">81</xref> thus, early propagation networks can be anchored by analyzing semiology patterns and employed to find SOZ and predict the EZ.</p>
        <p>Many patients with surgically feasible SHE have no identifiable lesions on cranial MRI.<xref rid="cit0004" ref-type="bibr">4</xref> If, at the same time, the scalp EEG in such patients does not provide sufficient lateralization and localization information,<xref rid="cit0004" ref-type="bibr">4</xref> ictal semiology is highly suggestive in the preoperative evaluation. After targeting the region of interest by ictal semiology, a more targeted review of MRI or its combination with functional imaging data can help identify some subtle lesions, improve the rate of positive results by MRI, and facilitate a more precise prediction of the EZ, or provide a basis for subsequent intracranial electrode implantation, enabling a significant proportion of MRI-negative patients with SHE to benefit from surgical treatment as early as possible.</p>
        <sec id="s0003-s2002-s3001">
          <title>Aura</title>
          <p>An aura is a completely subjective symptom that occurs during an epileptic seizure, usually at the beginning of the seizure, and therefore often provides very useful information about the localization of the SOZ. Although most seizures in patients with SHE emerge from sleep, patients have fewer complaints about auras. Auras during wakefulness seizure events in these patients may have localization values.<xref rid="cit0056" ref-type="bibr">56</xref> For example, abdominal auras, auditory auras, and déjà vu suggest that the seizure originates in the temporal lobe;<xref rid="cit0085" ref-type="bibr">85</xref> the feeling of throat constriction, a choking sensation, and unpleasant somatosensory auras, such as pain, suggest that the seizure originates in the insula and operculum;<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0061" ref-type="bibr">61</xref> and somatic sensations and complex proprioceptive sensations, such as feelings of levitation, vertigo, and falling sensations, suggest seizures originating in the parietal lobe.<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0062" ref-type="bibr">62</xref> Cephalic auras and whole-body auras have been observed in frontal SHE; these auras can arise from the entorhinal cortex, lateral temporal neocortex, second sensory area, and supplementary sensorimotor area but often lack clear localizing value.<xref rid="cit0086" ref-type="bibr">86</xref>,<xref rid="cit0087" ref-type="bibr">87</xref> However, these nonspecific auras were common in both frontal lobe epilepsy and the frontal SHE subgroup, thus increasing the localization yield when present.<xref rid="cit0005" ref-type="bibr">5</xref></p>
        </sec>
        <sec id="s0003-s2002-s3002">
          <title>Seizure Semiology Patterns of Different Origins</title>
          <p>The semiological seizure classification of hypermotor seizures was proposed and defined by Luders in 1998 and the terminology committee of the International league against epilepsy in 2001.<xref rid="cit0085" ref-type="bibr">85</xref>,<xref rid="cit0088" ref-type="bibr">88</xref> To explore the epileptogenic networks involved in various types of hypermotor symptoms, scholars such as Rheims<xref rid="cit0052" ref-type="bibr">52</xref> and Montavont<xref rid="cit0089" ref-type="bibr">89</xref> classified hypermotor seizures (HMS) into three categories (<xref rid="f0002" ref-type="fig">Figure 2</xref>): patients with HMS type 1 have strong negative emotions (eg, fear, anger) and agitated, but relatively coordinated movements, including body rocking, pedaling or boxing, and sitting or standing up from the bed;<xref rid="cit0052" ref-type="bibr">52</xref>,<xref rid="cit0089" ref-type="bibr">89</xref> patients with HMS type 2 have relatively mild emotions and less agitated movements, including horizontal movements or rotation of the trunk and pelvis, accompanied by tonic/dystonic postures, without leaving the bed;<xref rid="cit0052" ref-type="bibr">52</xref>,<xref rid="cit0089" ref-type="bibr">89</xref> and patients with the mixed type of HMS mainly present with repetitive movements of the bimanual bipedal and pelvic movements, including kicking and pelvic thrust, often without leaving the bed, and these may be accompanied by strong gripping or dystonia.<xref rid="cit0089" ref-type="bibr">89</xref> Gibbs et al analyzed the SOZ of 135 patients with SHE confirmed by a video EEG (VEEG) through preoperative anatomic-electro-clinical data (including SEEG), postoperative head MRI, and postoperative Engel’s classification and summarized four seizure semiology patterns (SPs) of SHE:<xref rid="cit0005" ref-type="bibr">5</xref> SP1 involves early elementary motor signs and asymmetrical tonic posture, which may be combined with clonus; SP2 involves unnatural hypermotor movements, axial tonic posture, nonverbal vocalization, and facial contractions (ictal pouting); SP3 involves integrated hypermotor movements, such as pedaling behavior, which may be combined with distal limb stereotypy, speech, and manipulation behaviors; and SP4 is characterized by gestural behavior with high emotional content, including strong negative emotions, fearful facial expressions, and fight or flight behaviors, such as paroxysmal wandering, which may be combined with autonomic symptoms. In the above typing, if more than one motor symptom is exhibited, the patient is typed according to the earliest motor symptoms present.<xref rid="cit0005" ref-type="bibr">5</xref><fig position="float" id="f0002" fig-type="figure"><label>Figure 2</label><caption><p>Schematic representation of the seizure semiology patterns of SHE derived from anatomical-electrical-clinical data.</p></caption><graphic xlink:href="NSS-13-2065-g0002" content-type="print-only" position="float"/><attrib><bold>Notes</bold>: The seizure semiology patterns were grouped in three categories (HMS type 1 and 2 and mixed type of HMS) and depicted by three different colors (red, light red, and yellow). Although there were no strict boundaries among the color-coded groups, the specific HMS type contributed to the prediction of the EZ .</attrib><attrib><bold>Abbreviation</bold>: HMS, hypermotor seizures.
</attrib></fig></p>
        </sec>
        <sec id="s0003-s2002-s3003">
          <title>SHE of Frontal Lobe Origin</title>
          <p>Based on functional anatomical and electro-clinical data of the frontal lobe, the frontal lobe epileptic semiology pattern and its localization value have been extensively studied. The more posterior the EZ (ie, close to the caudal primary motor cortex of the frontal lobe), the more likely it is that elementary motor signs, such as clonus, contralateral tonic posturing, and contralateral version, will be present during seizures.<xref rid="cit0090" ref-type="bibr">90</xref> The more anterior the EZ (ie, near the rostral side of the frontal lobe-frontal pole, orbitofrontal cortex), the more coordinated the patient’s movements will be during seizures, often accompanied by emotional responses, such as fearful facial expressions.<xref rid="cit0090" ref-type="bibr">90</xref> Fear-like behaviors are associated with the frontal or frontotemporal paralimbic system.<xref rid="cit0090" ref-type="bibr">90</xref> SEEG data confirmed<xref rid="cit0052" ref-type="bibr">52</xref>,<xref rid="cit0089" ref-type="bibr">89</xref> that the SOZ suggested by different types of frontal HMS also follow the “rostrocaudal axis pattern” of frontal semiology (<xref rid="f0002" ref-type="fig">Figure 2</xref>). The SOZ associated with HMS type 1 is concentrated in the ventromedial frontal cortex, including the orbitofrontal cortex (OFC), rostral side of the anterior cingulate cortex (ACC), and frontal pole.<xref rid="cit0052" ref-type="bibr">52</xref>,<xref rid="cit0089" ref-type="bibr">89</xref> Discharge during seizures can be transmitted to the temporal lobe, caudal side of the ACC, insula lobe, and transitional cortex between the prefrontal and premotor cortex. The SOZ associated with HMS type 2 is mainly located on the medial side of the premotor cortex, the caudal side of the ACC, and transition cortex between the prefrontal lobe and the premotor cortex.<xref rid="cit0052" ref-type="bibr">52</xref>,<xref rid="cit0089" ref-type="bibr">89</xref> The SOZ associated with the mixed type of HMS is located primarily in the transitional cortex between the prefrontal and premotor cortices.<xref rid="cit0089" ref-type="bibr">89</xref> Similarly, among the four SPs of SHE defined by Gibbs et al,<xref rid="cit0005" ref-type="bibr">5</xref> the frontal lobe groups of SHE follow an “anteroposterior” distribution pattern, that is, the SOZ of SP1 is mainly located near the precentral sulcus, and the SOZ of SP4 is mainly located near the frontal pole and the OFC. The SOZs of SP2 and SP3 are more dispersed but follow the same “anteroposterior” trend. It is more difficult to distinguish between SP2 and SP3, and they are not as useful for localization as SP1 and SP4.<xref rid="cit0005" ref-type="bibr">5</xref> The correlation between semiology pattern typing and the SOZ of both Gibbs<xref rid="cit0005" ref-type="bibr">5</xref> and Rheims<xref rid="cit0052" ref-type="bibr">52</xref> methods follows the same rule: from the rostral to the caudal side of the frontal lobe, the hypermotor symptoms range from complex to simple, from relatively coordinated to uncoordinated or unnatural hypermotor movements (often manifested as asymmetrical hypermotor movements with dystonia), with more emotional responses on the ventral side of the medial prefrontal lobe.<xref rid="cit0090" ref-type="bibr">90</xref>,<xref rid="cit0091" ref-type="bibr">91</xref> The OFC, dorsolateral prefrontal cortex, amygdala, and ACC are key structures primarily involved in the emotional regulation circuit, and abnormalities in one of these interconnected structures or their interconnections can alter emotional regulation and increase impulsive aggression and violent tendencies.<xref rid="cit0092" ref-type="bibr">92</xref> Using a computational model of EEG activity and nonlinear correlation analysis, the correlations between certain specific structures of the emotional network (eg, the amygdala, OFC, ACC, and temporal pole) were found to be significantly reduced in patients with frontal lobe epilepsy during the ictal phase compared to those during the background phase; in particular, the correlation between the OFC and amygdala was the most pronounced, thus leading to inhibition dissolution of negative emotions and corresponding agitated behaviors.<xref rid="cit0093" ref-type="bibr">93</xref> This could explain the negative emotions present in patients with SHE exhibiting HMS type 1 and SP4 (<xref rid="f0002" ref-type="fig">Figure 2</xref>).</p>
        </sec>
        <sec id="s0003-s2002-s3004">
          <title>SHE of Temporal Lobe Origin</title>
          <p>According to a summary of previous literature, patients with temporal SHE have a greater tendency to exhibit more integrated hypermotor behaviors (HMS type 1 or SP3 and SP4), usually of the distal limbs and accompanied by more intense negative emotions (<xref rid="f0002" ref-type="fig">Figure 2</xref>).<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0094" ref-type="bibr">94</xref>,<xref rid="cit0095" ref-type="bibr">95</xref> The EZ of temporal SHE is mainly located in the anterior inferior temporal cortex (parahippocampal gyrus, anterior inferior temporal gyrus), temporal pole, and amygdala.<xref rid="cit0096" ref-type="bibr">96</xref>,<xref rid="cit0097" ref-type="bibr">97</xref> Readings from subdural electrodes in a hypermotor patient with a temporal pole lesion confirmed that the low-voltage fast activity at the seizure’s onset began in the inferolateral anterior temporal lobe, and the patient developed hypermobility symptoms when a slow-wave rhythm appeared in the OFC, indicating that hypermotor seizures associated with temporal pole lesions are caused by the spread of discharges to the frontal lobes.<xref rid="cit0091" ref-type="bibr">91</xref>,<xref rid="cit0094" ref-type="bibr">94</xref> The SEEG data also confirmed that the temporal pole and OFC are the most important in the HMS epileptogenic network of temporal lobe origin and that the amygdala is also involved.<xref rid="cit0097" ref-type="bibr">97</xref> As previously mentioned, the diminished correlation between these emotional network structures in the temporal pole and the OFC results in emotion-related release signs. This could also explain the negative emotions in the semiology of patients with temporal lobe SHE.</p>
        </sec>
        <sec id="s0003-s2002-s3005">
          <title>SHE of Insula Lobe Origin</title>
          <p>The insula lobe is a tissue deep in the brain covering the frontal, parietal, and temporal opercula. Because of the rich connectivity of the insula to the surrounding lobes, discharges originating in the insula have multiple propagation pathways, including the lateral sulcus, frontal lobe, and temporal lobe. Insular lobe epilepsy can mimic the symptoms of frontal, temporal, and parietal lobe epilepsy, often exhibiting a semiology of the cortices associated with the areas of discharge propagation. Therefore, it is difficult to diagnose clinically and tends to be misdiagnosed, and thus has been described as a great mimic.<xref rid="cit0098" ref-type="bibr">98</xref> Many scholars have successively reported patients with NFLE and insular seizure onset confirmed by intracranial electrodes.<xref rid="cit0064" ref-type="bibr">64</xref> These paroxysmal events mainly occurred during sleep and presented with symptoms of horizontal trunk hypermotor movements, asymmetric tonic/dystonic postures, and asymmetric pedaling.<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0099" ref-type="bibr">99</xref> The SEEG recordings confirmed that ictal discharges started from the insula and hypermotor manifestations appeared when they spread to the cingulate cortex, superior frontal gyrus, supplementary motor area (SMA), and pre-SMA.<xref rid="cit0064" ref-type="bibr">64</xref>,<xref rid="cit0099" ref-type="bibr">99</xref> Moreover, 5–40 s intervals between the ictal onset and hypermotor manifestations were observed using SEEG in these patients,<xref rid="cit0099" ref-type="bibr">99</xref> which also suggested that hypermotor seizures in the insula are a symptom that appears after discharge diffusion. Patients with insular SHE have a greater tendency to show a semiology of HMS type 2 and mixed types or SP1 and SP2, whereas, in general, SP4 is not observed.<xref rid="cit0005" ref-type="bibr">5</xref> However, when the SOZ or propagation networks involve the anterior insula, it can be accompanied by strong emotional responses. Ryvlin reported that three patients had hypermotor seizures of anterosuperior insular origin, confirmed by intracranial electrodes.<xref rid="cit0064" ref-type="bibr">64</xref> Each patient also expressed fear because the ventral anterior insula is involved in emotional processing.<xref rid="cit0100" ref-type="bibr">100</xref>,<xref rid="cit0101" ref-type="bibr">101</xref> According to the anatomic-electro-clinical data of insular lobe epilepsy by Wang et al,<xref rid="cit0102" ref-type="bibr">102</xref> based on the Brainnetome Atlas, the semiology followed the anteroposterior “anteroventral to posterodorsal axis” distribution pattern. The semiology pattern in a group of patients with an epileptic network involving the anteroventral insular regions showed integrated gestural motor behaviors or feelings of rage or fear, whereas that in a group of patients with an epileptic network involving the posterodorsal insular regions showed non-integrated gestural motor behaviors or asymmetric tonic posture (<xref rid="f0002" ref-type="fig">Figure 2</xref>).<xref rid="cit0102" ref-type="bibr">102</xref></p>
        </sec>
        <sec id="s0003-s2002-s3006">
          <title>SHE of Parietal Origin</title>
          <p>In addition to the postcentral gyrus, the parietal cortex includes the superior parietal lobule, inferior parietal lobule, and parietal operculum.<xref rid="cit0103" ref-type="bibr">103</xref> In previous studies, the main clinical features of parietal SHE included asymmetric “hypermotor” events and dystonia<xref rid="cit0091" ref-type="bibr">91</xref> and were associated with an SOZ in the inferior parietal lobule, parietal operculum, or posterior cingulate cortex (PCC).<xref rid="cit0091" ref-type="bibr">91</xref>,<xref rid="cit0104" ref-type="bibr">104</xref>,<xref rid="cit0105" ref-type="bibr">105</xref> Bartolomei et al analyzed 17 patients with epilepsy in the posterior parietal cortex (including the superior parietal lobule, inferior parietal lobule, and parietal operculum),<xref rid="cit0105" ref-type="bibr">105</xref> of whom four patients with EZs located in the parietal operculum or inferior parietal lobule exhibited hypermotor movements and dystonic or tonic posture, tending to fit the HMS type 2 or SP1 and SP2 (<xref rid="f0002" ref-type="fig">Figure 2</xref>). In contrast, no hypermotor seizures were observed in patients with epilepsy in the superior parietal lobule. Contralateral dystonia, and ipsilateral hemiballic-like movements could be observed in patients with epilepsy in the inferior parietal lobule and parietal operculum. The “hemiballic-like” movement can be considered a useful clue to the localization and lateralization of the SOZ.<xref rid="cit0104" ref-type="bibr">104</xref> The connection between the parietal operculum and premotor cortex may underlie the anatomy of hypermotor movement in patients with parietal operculum epilepsy.<xref rid="cit0106" ref-type="bibr">106</xref></p>
          <p>In summary, seizure SPs facilitate the prediction of SOZ localization in patients with frontal and extrafrontal SHE. Based on the intracranial electrode data and evidence of semiology, the anatomical-electrical clinical features in patients with SHE are summarized in <xref rid="f0002" ref-type="fig">Figure 2</xref>; however, it is worth noting that there are extensive functional connections between the cerebral cortices, and the propagation of discharges is dynamic and rapid. The mode of propagation also affects the seizures’ clinical manifestations. Differences in SP reflect the spread of seizures in different brain regions that may constitute different epileptogenic networks. Thus, although these localization trends exist in different SPs, seizure SPs cannot be completely and strictly separated from each other.</p>
        </sec>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Electrophysiological Features and Imaging Manifestations of SHE</title>
      <p>Long-term VEEG monitoring can increase the chances of detecting EEG abnormalities because the violent movements of patients with SHE during seizures lead to a large number of action artifacts in the EEG that affect judgment, or the EZ may be at relatively deep locations, such as the orbitofrontal gyrus or medial structures, so that ictal and interictal scalp EEGs often cannot provide clear diagnostic information.<xref rid="cit0006" ref-type="bibr">6</xref>,<xref rid="cit0009" ref-type="bibr">9</xref> However, even if the EEG fails to provide clear information, the diagnosis of SHE may not be excluded.<xref rid="cit0004" ref-type="bibr">4</xref> Gibbs retrospectively analyzed 58 patients with refractory SHE (43 in the frontal lobe and 15 extrafrontal) who underwent surgery. All patients underwent preoperative SEEG recordings and achieved freedom from seizures at 2 years of follow-up (Engel class I). The included patients were classified as having seizures of frontal or extrafrontal origin, according to the localization information acquired by SEEG.<xref rid="cit0107" ref-type="bibr">107</xref> The seizure duration was longer in the SHE of extrafrontal origin than in that of frontal origin (mostly less than 30 s), and the mean latency between the onset of an electrographic seizure and the appearance of hypermotor manifestations of extrafrontal SHE was also longer than that of frontal SHE. During video monitoring, a latency &gt; 5 s between the first observed action (eg, eye-opening or a mild motor event) and the appearance of hypermotor manifestations exhibited a diagnostic sensitivity of 75% and a specificity of 90% for extrafrontal SHE.<xref rid="cit0107" ref-type="bibr">107</xref> This time interval often coincides with the patient’s duration of arousal, suggesting that it is not the hypermotor behavior itself but the recruitment and propagation of electrical activity that causes arousal in patients with SHE.<xref rid="cit0056" ref-type="bibr">56</xref> Considering that this feature can be obtained through noninvasive video analysis, it could be a valuable clinical clue for diagnosing extrafrontal SHE.</p>
      <p>Gibbs et al analyzed 135 patients with SHE who underwent epilepsy surgery, of whom 65% had MRI-identifiable lesions. Of these, 52% had an MRI diagnosis of “probable FCD.” Of the 47 patients with normal MRI results, the most common postoperative pathology was FCD type II (51%), followed by nonspecific gliosis (23%) and FCD type I (21%).<xref rid="cit0005" ref-type="bibr">5</xref></p>
    </sec>
    <sec id="s0005">
      <title>Diagnostic Criteria for SHE</title>
      <p>As mentioned above, the diagnosis of SHE is mainly based on the patient’s clinical history because of the limited value of ictal and interictal scalp EEG for the localization and lateralization of the SOZ in patients with SHE and the low positive rate of neuroimaging (<xref rid="t0002" ref-type="table">Table 2</xref>).<table-wrap position="float" id="t0002"><label>Table 2</label><caption><p>Diagnostic Criteria of SHE</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="2" rowspan="1"><bold>Diagnostic Elements</bold></td></tr><tr><td rowspan="4" colspan="1">Seizure features (essential elements)</td><td rowspan="1" colspan="1">Sudden onset and offset, brief (less than 2 min), stereotyped motor patterns within individuals</td></tr><tr><td rowspan="1" colspan="1">Motor patterns: vigorous hypermotor movements or asymmetric dystonic/tonic posturing</td></tr><tr><td rowspan="1" colspan="1">Abrupt arousal or aura at the beginning of the seizure (Awareness of episodes are not an exclusion criterion)</td></tr><tr><td rowspan="1" colspan="1">Seizure frequency: every or almost every night, usually many times per night (Clustering is characteristic but not obligatory for diagnosis)</td></tr><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1">Occur at any age, predominance in childhood and adolescence (Seizures can also originate in adulthood)</td></tr><tr><td rowspan="1" colspan="1">Distribution of sleep/awake seizures</td><td rowspan="1" colspan="1">Mainly during sleep, mostly during NREM sleep, rarely during REM sleep, and occasionally during wakefulness (No clearly defined standards of distribution of sleep/awake seizures)</td></tr><tr><td rowspan="1" colspan="1">Intelligence</td><td rowspan="1" colspan="1">Usually have average intelligence, intellectual impairments have been reported (Intellectual impairments are not an exclusion criterion)</td></tr><tr><td rowspan="1" colspan="1">Scalp EEG</td><td rowspan="1" colspan="1">Definite epileptic discharges or interictal epileptiform abnormalities (Normal interictal or ictal scalp EEG are not an exclusion criterion)</td></tr><tr><td colspan="2" rowspan="1"><bold>Diagnostic Levels</bold></td></tr><tr><td rowspan="1" colspan="1">Witnessed/possible SHE</td><td rowspan="1" colspan="1">A typical clinical history (obvious and violent hypermotor events) provided by witnesses are sufficient</td></tr><tr><td rowspan="1" colspan="1">Video-documented/clinical SHE</td><td rowspan="1" colspan="1">At least one but preferably two complete events (confirmed by the witness as typical) in the video records are sufficient (A minor motor event or paroxysmal arousal by video records are not sufficient)</td></tr><tr><td rowspan="1" colspan="1">Video EEG-documented/confirmed SHE</td><td rowspan="1" colspan="1">Hypermotor seizures associated with definite epileptic discharges or interictal epileptiform abnormalities recorded during sleep, with the use of a VEEG at least 19 channels, an electrocardiogram, electrooculography, and chin electromyogram<break/>Documentation should include daytime sleep recordings after sleep deprivation or nighttime sleep recordings</td></tr></tbody></table><table-wrap-foot><fn id="tfn0002"><p><bold>Note</bold>: Data from references <xref rid="cit0004" ref-type="bibr">4</xref> and <xref rid="cit0151" ref-type="bibr">151</xref>.</p></fn><fn id="tfn0003"><p><bold>Abbreviations</bold>: NREM, non-rapid eye movement sleep; REM, rapid eye movement sleep; EEG, electroencephalography; VEEG, video- electroencephalography; SHE, sleep-related hypermotor epilepsy.</p></fn></table-wrap-foot></table-wrap>
</p>
      <p>The diagnosis can be divided into three levels: witnessed (possible) SHE, video-documented (clinical) SHE, and VEEG-documented (confirmed) SHE.<xref rid="cit0004" ref-type="bibr">4</xref> In witnessed (possible) SHE, semiologically, there are obvious and violent hypermotor events, generally concordant with those documented by video analysis. Therefore, the data provided by a good clinical history are sufficient to diagnose witnessed (possible) SHE. In video-documented (clinical) SHE, at least one, but preferably two, complete events (confirmed by the witness as typical) should be documented in the video records, including the onset, evolution, and offset of the entire event. If a minor motor event or paroxysmal arousal is captured, the clinical diagnosis may not be reliable.<xref rid="cit0004" ref-type="bibr">4</xref> In VEEG-documented (confirmed) SHE, the confirmation of a SHE diagnosis requires the use of a VEEG of at least 19 channels, an electrocardiogram, electrooculography, and chin electromyogram. Documentation should include daytime sleep recordings after sleep deprivation or nighttime sleep recordings. The diagnosis of SHE can be confirmed when hypermotor seizures associated with definite epileptic discharges or interictal epileptiform abnormalities are recorded during sleep.<xref rid="cit0004" ref-type="bibr">4</xref> However, the proportion of seizures during sleep to those during wakefulness is not currently specified in the diagnostic criteria for SHE.</p>
    </sec>
    <sec id="s0006">
      <title>Differential Diagnosis and Overlap Between SHE and Parasomnias</title>
      <p>Great progress has been made in the identification of these sleep-related seizures with hypermotor automatisms and/or dystonic posturing as a unique syndrome. However, the differential diagnosis between the syndrome and paroxysmal non-epileptic motor events may still be challenging. Parasomnias are undesirable behavioral events or complex motor that occur during entry to sleep, within sleep, or during sleep arousal.<xref rid="cit0108" ref-type="bibr">108</xref> Most feature nocturnal paroxysmal motor phenomena, and their distinction from SHE can be difficult, particularly when distinguishing disorders of arousal (DOA) or REM sleep behavior disorder (RBD) from SHE. RBD is a common type of REM parasomnia characterized by the loss of normal skeletal muscle atonia with prominent dreaming and abrupt motor activity.<xref rid="cit0109" ref-type="bibr">109</xref> Complex behaviors with violent acts (punching or kicking) or bed falls can also occur.<xref rid="cit0110" ref-type="bibr">110</xref> RBD affects predominantly elderly men (aged ≥50 years), and episodes prevail at least 90 minutes after sleep onset (more common in the second half of the night).<xref rid="cit0059" ref-type="bibr">59</xref> DOA are NREM parasomnias characterized by complex, seemingly purposeful, goal-directed behavioral events during NREM sleep.<xref rid="cit0108" ref-type="bibr">108</xref> The prevalence of DOA in patients with SHE and their relatives is high, and DOA and SHE may coexist in the same patient or family members of the patient.<xref rid="cit0049" ref-type="bibr">49</xref> Patients with sleep-related motor and behavioral disorders present to a variety of specialist outpatient centers (neurology, sleep medicine, psychiatry). The difficult diagnosis leads to significant distress for the patients, with consequences on their quality of life. It is impossible to distinguish epileptic seizures from parasomnias solely from certain semiological manifestations (eg, screaming or walking). Different core clinical features should be the first step for the differential diagnosis of SHE and parasomnias (<xref rid="t0003" ref-type="table">Table 3</xref>). Distinct from patients with SHE (as described in the preceding paragraphs), those with DOA usually present with variable, complex, and non-stereotyped motor episodes.<xref rid="cit0111" ref-type="bibr">111</xref> Core clinical features are strongly supporting a diagnosis of DOA include behaviors mimicking everyday activities associated with physical or verbal interaction with the environment (such as turning on the light, opening a door or looking out of the window, using the mobile phone, getting dressed, taking actions related to working activity, doing make-up or preparing luggage).<xref rid="cit0112" ref-type="bibr">112</xref> Patients with parasomnia often have lower episode frequency and longer episode duration than those with SHE.<xref rid="cit0113" ref-type="bibr">113</xref> The clinical history alone is sometimes insufficient to provide information for differential diagnosis but may still provide clues for the further development of screening programs. To obtain a systematic assessment of the diagnostic accuracy of clinical history in distinguishing SHE from parasomnias, two instruments have been devised: the Structured Interview for NFLE<xref rid="cit0050" ref-type="bibr">50</xref> and the Frontal Lobe Epilepsy and Parasomnias scale.<xref rid="cit0114" ref-type="bibr">114</xref> However, despite their clinical usefulness, their diagnostic accuracy is insufficient.<xref rid="cit0115" ref-type="bibr">115</xref>,<xref rid="cit0116" ref-type="bibr">116</xref> VEEG recordings might yield an improved clinical discrimination, but not all patients with SHE exhibit EEG abnormalities, and EEG epileptiform abnormalities may also occur in some patients with RBD.<xref rid="cit0109" ref-type="bibr">109</xref> This adds to the difficulties of successful diagnosis. Standard VEEG, used to monitor for seizures in inpatient epilepsy monitoring units, typically utilizes 19 EEG channels, electrocardiogram, and deltoids electromyography, without electrooculography and chin electromyogram. VEEG studies are not adequate for the purposes of determining sleep state and provide insufficient information regarding whether a potential sleep disorder is present due to the lack of chin electromyogram and respiratory channels. Video polysomnography was once considered the gold standard for the diagnosis of paroxysmal nocturnal events. While standard PSG typically utilizes 4–6 channels of VEEG, this is not sufficient to evaluate EEG epileptiform activity.<xref rid="cit0117" ref-type="bibr">117</xref> In seizure monitoring (whether PSG or VEEG), the amount of seizures is often the limiting factor, as some patients have a low seizure frequency. Home-made video can be very useful in the diagnosis of major motor episodes when the patients do not recall episodes. Due to this, combined VEEG and PSG, utilizing 19-channel EEG and other physiological parameters, can assist in diagnosing suspicious nocturnal events and differentiating between the presence of a parasomnia, seizure activity, or both.<xref rid="cit0004" ref-type="bibr">4</xref>,<xref rid="cit0118" ref-type="bibr">118</xref>,<xref rid="cit0119" ref-type="bibr">119</xref> Considering the identification of semiology is highly dependent on clinician expertise and skills, some scholars have postulated that the relative time and stage of occurrence during sleep of minor and major episodes could represent objective and simple criteria to discriminate SHE from DOA. The occurrence of at least one major event (complex arousal ambulatory movements in DOA<xref rid="cit0120" ref-type="bibr">120</xref> and complex hypermotor seizures in SHE<xref rid="cit0004" ref-type="bibr">4</xref>) outside stage N3 sleep was highly suggestive of SHE (accuracy = 0.898, specificity = 0.949, sensitivity = 0.793), whereas the occurrence of at least one minor event (simple and rising arousal movements in DOA,<xref rid="cit0120" ref-type="bibr">120</xref> MME and PAs in SHE<xref rid="cit0004" ref-type="bibr">4</xref>) during stage N3 sleep was highly suggestive of DOA (accuracy = 0.73, specificity = 0.723, sensitivity = 0.733).<xref rid="cit0121" ref-type="bibr">121</xref> Despite the majority of patients being diagnosed with typical clinical history, 19-channel EEG recordings combined with PSG, and homemade video, a substantial number remain undiagnosed.<table-wrap position="float" id="t0003"><label>Table 3</label><caption><p>Differential Diagnosis of SHE</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Clinical Features</th><th rowspan="1" colspan="1">SHE</th><th rowspan="1" colspan="1">DOA</th><th rowspan="1" colspan="1">RBD</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Time of night</td><td rowspan="1" colspan="1">No pattern</td><td rowspan="1" colspan="1">Usually within 90 minutes of sleep onset</td><td rowspan="1" colspan="1">At least 90 minutes after sleep onset, more common in the second half of the night</td></tr><tr><td rowspan="1" colspan="1">Sleep staging</td><td rowspan="1" colspan="1">NREM I or II</td><td rowspan="1" colspan="1">NREM III</td><td rowspan="1" colspan="1">REM</td></tr><tr><td rowspan="1" colspan="1">Episode pattern</td><td rowspan="1" colspan="1">Stereotyped and purposeless</td><td rowspan="1" colspan="1">Non-stereotyped variable but often complex</td><td rowspan="1" colspan="1">Complex and rough</td></tr><tr><td rowspan="1" colspan="1">Episode frequency</td><td rowspan="1" colspan="1">Every or almost every night, usually many times per night</td><td rowspan="1" colspan="1">Few per week</td><td rowspan="1" colspan="1">Variable, can be every night</td></tr><tr><td rowspan="1" colspan="1">Duration of episodes</td><td rowspan="1" colspan="1">Brief, often less than 2 min</td><td rowspan="1" colspan="1">1–30 minutes</td><td rowspan="1" colspan="1">Fewer than 10 minutes</td></tr><tr><td rowspan="1" colspan="1">Dream mentation</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Uncommon</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">Eyes during episode</td><td rowspan="1" colspan="1">Open</td><td rowspan="1" colspan="1">Open</td><td rowspan="1" colspan="1">Mostly closed</td></tr><tr><td rowspan="1" colspan="1">Age of onset</td><td rowspan="1" colspan="1">Variable, predominance in childhood and adolescence</td><td rowspan="1" colspan="1">Childhood</td><td rowspan="1" colspan="1">Older than 50 years in idiopathic cases</td></tr><tr><td rowspan="1" colspan="1">Family history</td><td rowspan="1" colspan="1">Common</td><td rowspan="1" colspan="1">Common</td><td rowspan="1" colspan="1">Rare</td></tr><tr><td rowspan="1" colspan="1">Episodes during daytime</td><td rowspan="1" colspan="1">Sometimes</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td></tr></tbody></table><table-wrap-foot><fn id="tfn0004"><p><bold>Notes</bold>: These clinical features are more prominent in one class than in the other; however, these divisions are not always absolute. Data from references.<xref rid="cit0111" ref-type="bibr">111</xref>,<xref rid="cit0113" ref-type="bibr">113</xref>,<xref rid="cit0121" ref-type="bibr">121</xref>,<xref rid="cit0149" ref-type="bibr">149</xref>,<xref rid="cit0150" ref-type="bibr">150</xref></p></fn><fn id="tfn0005"><p><bold>Abbreviations</bold>: SHE, sleep-related hypermotor epilepsy; DOA, disorders of arousal; REM, rapid eye movement; RBD, rapid eye movement sleep behavior disorder; NREM, non-rapid eye movement.</p></fn></table-wrap-foot></table-wrap>
</p>
      <p>More and more researchers are starting to explore the possible intrinsic link between SHE and some parasomnias as they share common semiological features. It has been speculated that the similarities in motor behaviors observed with SHE and parasomnias are due to the activation of central pattern generators (CPGs).<xref rid="cit0122" ref-type="bibr">122</xref>,<xref rid="cit0123" ref-type="bibr">123</xref> CPGs are groups of interconnected nerve cells in the spinal cord, brainstem, and other subcortical regions that activate different motor neurons in the proper sequence and intensity to generate stereotyped motor responses such as locomotion.<xref rid="cit0124" ref-type="bibr">124</xref> In neonates, fundamental motor functions (protective reflexes like grasping and avoidance, pedaling, wandering, and cyclic leg movements) are carried out by CPGs. In adults, these motor behaviors are under the control of the neocortex. Both physiological (sleep) and pathological (seizure-related) conditions can also lead to a transient loss of control of the neocortex with a lack of CPGs inhibition.<xref rid="cit0122" ref-type="bibr">122</xref>,<xref rid="cit0125" ref-type="bibr">125</xref>,<xref rid="cit0126" ref-type="bibr">126</xref> Thus, many scholars believe that the release of inborn fixed motor behaviors may account for the semiological overlap between SHE and some parasomnias.<xref rid="cit0055" ref-type="bibr">55</xref>,<xref rid="cit0122" ref-type="bibr">122</xref>,<xref rid="cit0123" ref-type="bibr">123</xref> These motor patterns are already written in the brain codes (CPGs) but require a degree of activation to become visibly apparent. In general, arousal during sleep acts as a trigger releasing or facilitating an encoded inborn fixed motor behaviors.<xref rid="cit0055" ref-type="bibr">55</xref> Numerous studies have provided support for this point of view and showed that a high number of micro-arousals was seen in both SHE and NREM parasomnias.<xref rid="cit0055" ref-type="bibr">55</xref>,<xref rid="cit0127" ref-type="bibr">127</xref> The presence of sleep state instability is characterized by recurrent arousals that are thought to serve as the initiating source of the NREM parasomnias.<xref rid="cit0128" ref-type="bibr">128</xref> SEEG studies have shown that epileptiform discharges would act as an internal trigger increasing micro-arousal and sleep instability and, in turn, enhance and modulate the occurrence of motor events (epileptic or not) or different types of sleep disturbances.<xref rid="cit0055" ref-type="bibr">55</xref>,<xref rid="cit0056" ref-type="bibr">56</xref>,<xref rid="cit0129" ref-type="bibr">129</xref>,<xref rid="cit0130" ref-type="bibr">130</xref> On the other hand, the resulting sleep instability might facilitate the production of epileptic discharges in a bi-directionally influenced system and, in turn, promote seizure activity.<xref rid="cit0055" ref-type="bibr">55</xref>,<xref rid="cit0056" ref-type="bibr">56</xref>,<xref rid="cit0129" ref-type="bibr">129</xref>,<xref rid="cit0130" ref-type="bibr">130</xref> Thus, it is not difficult to understand why the removal of the EZ after epilepsy surgery may not only eliminate major epileptic episodes but also improve sleep quality and sleep architecture (PSG documented).<xref rid="cit0006" ref-type="bibr">6</xref>,<xref rid="cit0131" ref-type="bibr">131</xref></p>
      <p>Several studies on the cyclic alternating pattern (CAP) also arrived at similar conclusions.<xref rid="cit0055" ref-type="bibr">55</xref>,<xref rid="cit0132" ref-type="bibr">132</xref> CAP is a physiologic component of NREM sleep that is functionally associated with arousal oscillations, which is a measure of NREM sleep instability.<xref rid="cit0128" ref-type="bibr">128</xref>,<xref rid="cit0133" ref-type="bibr">133</xref> CAP is composed of phase A (including sequences of K-complexes, EEG arousals, bursts of polymorphic delta or alpha waves, and vertex waves) and phase B (intervening background between two consecutive A phases).<xref rid="cit0128" ref-type="bibr">128</xref> Phase A is the EEG marker of cerebral activation and unstable sleep phases, including cortical arousal, and for this reason, it is considered a potential trigger of somatomotor activities.<xref rid="cit0134" ref-type="bibr">134</xref> Phase A of the CAP could not be only in favor of the co-occurrence of MMEs and epileptic discharges but also create a reciprocal facilitating effect. In earlier studies, major motor episodes (lasting between 10 and 60 s) in patients with SHE were preceded by a prolonged CAP sequence, which reflects a sustained condition of sustained arousal instability.<xref rid="cit0055" ref-type="bibr">55</xref>,<xref rid="cit0135" ref-type="bibr">135</xref> Taken together, arousal plays a key role for the release of motor activities, ranging from physiological body movements to nocturnal seizure and NREM parasomnias. Whether the motor outcome is a normal or a pathological motor episode will depend on a number of ongoing factors such as sleep stage, the susceptibility of the patient, the nature of the putative underlying lesion, and the location and extent of the neural circuits involved.<xref rid="cit0055" ref-type="bibr">55</xref> Mutations in the ACh receptor have been identified in some patients with ADSHE. Prior studies found increased nAChR density in the superior area of the epithalamus and cerebellum in patients with ADSHE<xref rid="cit0136" ref-type="bibr">136</xref> and increased nAChR density in the epithalamus and interpeduncular nucleus in patients with a sleep disorder.<xref rid="cit0137" ref-type="bibr">137</xref> The increased acetylcholine may participate regulation of sleep stability, especially micro-arousals, by activating the hyperactivation of the cholinergic pathway ascending from the brainstem.<xref rid="cit0014" ref-type="bibr">14</xref>,<xref rid="cit0138" ref-type="bibr">138</xref> Current opinion tends to consider that the possible pathophysiologic mechanism of the intrinsic link between SHE and parasomnias is the abnormal cholinergic arousal system.</p>
    </sec>
    <sec id="s0007">
      <title>Prognosis and Treatment of SHE</title>
      <sec id="s0007-s2001">
        <title>Prognosis of SHE</title>
        <p>Licchetta et al followed up 139 patients with SHE for up to 16 years, of whom 77.7% failed to reach 5 seizure-free years, thus pointing to a poor prognosis of SHE.<xref rid="cit0009" ref-type="bibr">9</xref> The most important factor affecting remission rates is the disease’s etiology.<xref rid="cit0009" ref-type="bibr">9</xref> Any underlying brain dysfunction, including perinatal insults, intellectual disability, abnormal neurologic examinations, structural brain abnormalities, and the presence of seizures during wakefulness, is a negative predictor of SHE prognosis.<xref rid="cit0009" ref-type="bibr">9</xref> Although sleep-related hypermotor seizures are a hallmark feature of SHE, up to half of the patients may experience seizures during wakefulness throughout their lifetime.<xref rid="cit0107" ref-type="bibr">107</xref> Given the greater impact on the quality of life (eg, driving limitations and social discrimination) of the presence of seizures during wakefulness in patients with SHE than that of seizures that only occur during sleep, a further analysis by Licchetta et al based on the same study population noted that the probability of the appearance of epileptic seizures in patients who only had seizures during sleep initially was 27%,<xref rid="cit0139" ref-type="bibr">139</xref> whereas that of the appearance of seizures during wakefulness throughout their lifetime for patients who had seizures during wakefulness from the beginning was 94%.<xref rid="cit0139" ref-type="bibr">139</xref></p>
      </sec>
      <sec id="s0007-s2002">
        <title>Treatment of SHE</title>
        <p>Carbamazepine inhibits the SHE-associated α4β2 and α2β4 subunits of the nicotinic acetylcholine receptor,<xref rid="cit0140" ref-type="bibr">140</xref> thereby inhibiting glutamatergic excitability and enhancing GABAergic activity in the thalamocortical system and hippocampus, thus altering neuronal excitability.<xref rid="cit0141" ref-type="bibr">141</xref> Low doses of carbamazepine (200–1,000 mg/kg) were effective in some patients with SHE<xref rid="cit0046" ref-type="bibr">46</xref>,<xref rid="cit0142" ref-type="bibr">142</xref> but appeared to be ineffective in at least one-third of patients.<xref rid="cit0132" ref-type="bibr">132</xref> In uncontrolled trials, oxcarbazepine and topiramate were effective against both familial and sporadic ADSHE.<xref rid="cit0143" ref-type="bibr">143</xref>,<xref rid="cit0144" ref-type="bibr">144</xref> Raju et al reported the significant efficacy of oxcarbazepine in eight children with NFLE who were nonresponsive to carbamazepine and other antiepileptic drugs.<xref rid="cit0145" ref-type="bibr">145</xref> Most epilepsy cases caused by mutations in the <italic toggle="yes">KCNT1</italic> gene, which encodes a sodium-activated potassium channel, are difficult to treat. Milligan et al suggested that quinidine, a partial antagonist of the <italic toggle="yes">KCNT1</italic> channel, could treat ADSHE due to <italic toggle="yes">KCNT1</italic> mutations.<xref rid="cit0024" ref-type="bibr">24</xref> Quinidine has been approved by the US Food and Drug Administration for the treatment of epilepsy caused by <italic toggle="yes">KCNT1</italic> mutations. However, a placebo-controlled clinical study conducted by Mullen et al confirmed the poor efficacy of quinidine on ADSHE and showed that the drug could lead to serious cardiac side effects.<xref rid="cit0146" ref-type="bibr">146</xref> The efficacy of quinidine as an emerging drug for epilepsy treatment needs to be verified in clinical studies with large sample sizes. Lacosamide acts on slowly inactivated sodium channels and is a potentially effective adjunctive therapy for patients with refractory SHE. Samarasekera et al treated eight patients with refractory SHE with lacosamide (300–600 mg/kg) and reduced seizure frequency by more than 50% in five patients and by 25% in one patient.<xref rid="cit0147" ref-type="bibr">147</xref> One of the pathogenic mechanisms of ADSHE is gain-of-function mutations in the α4 or β2 subunits of nAChRs, and fenofibrate, a common lipid-modulating drug, is an agonist of peroxisome proliferator-activated receptor-alpha and a ligand-activated transcription factor that negatively regulates the function of the β2-containing nAChRs. A preclinical and clinical study confirmed the efficacy of fenofibrate in transgenic mice carrying mutations in the α4-nAChR subunit homologous to those in humans and patients with drug-resistant SHE, suggesting a novel drug target for anti-epilepsy treatment.<xref rid="cit0148" ref-type="bibr">148</xref></p>
        <p>Gibbs et al conducted a 2-year postoperative follow-up of 127 surgically treated patients with SHE, of whom 104 (82%) had an Engel class I outcome, including 86 (68%) with an Engel class Ia outcome, and the lobar location of the SOZ showed no significant effect on postoperative outcomes.<xref rid="cit0005" ref-type="bibr">5</xref> Surgical treatment was effective in some severe drug-resistant patients with SHE-associated with FCD.<xref rid="cit0006" ref-type="bibr">6</xref> Genetic etiology is not a contraindication during preoperative evaluation, although there have not been many studies on the surgical outcomes of patients with known genetic mutations.<xref rid="cit0004" ref-type="bibr">4</xref></p>
      </sec>
    </sec>
    <sec id="s0008">
      <title>Summary</title>
      <p>SHE is a group of etiologically diverse clinical syndromes, and most SHEs have poor long-term control rates compared to overall remission rates in epilepsy. After a careful preoperative assessment, some drug-resistant patients with these syndromes can benefit from surgery. In recent years, anatomical-electrical-clinical data have improved our understanding of the epileptogenic network of this group of syndromes. And helped to predict potential EZs, which subsequently leads to improved chances of a good surgical outcome. SHE is characterized by the seizure pattern—the strange, abrupt hypermotor movements sometimes with high emotional content—which could be easily confused with some parasomnias or psychogenic events. The uninformative scalp EEG and MRI of some patients make an accurate diagnosis more difficult. This is especially relevant for clinicians and families less educated in epilepsy. The idea of a common semiology and genetic basis of SHE and parasomnias opens an interesting new direction for future research in this field. However, the epidemiology of SHE has not been adequately studied, and the relationship between clinical presentation homogeneity and etiologic heterogeneity has not been elucidated. Large randomized controlled studies to verify the aspects of treatment and prognosis are lacking. For this group of syndromes, we need population-based, multicenter epidemiological surveys and comprehensive analysis of data on multiple aspects, including the incidence, characteristic clinical seizure patterns, prognosis and disability rate, and improvement in the diagnosis of SHE. With the development of gene testing technology, more pathogenic mutations of ADSHE will be detected. Until now, there was no direct correlation between either known gene mutations and the disease severity or genetic result and efficacy. However, further studies will be required to establish the genotype-phenotype correlations of SHE, and further exploration of the effects of drugs and surgical treatments in patients with different etiologies and research on the disease’s etiology, especially genetic research, may provide new opportunities for targeted therapy for this group of syndromes.</p>
    </sec>
  </body>
  <back>
    <sec id="s0009">
      <title>Abbreviations</title>
      <p>ADSHE, autosomal dominant sleep-related hypermotor epilepsy; <italic toggle="yes">CABP</italic>, Ca(2+)-binding protein; <italic toggle="yes">CHRNA</italic>, gene encoding α subunit of the nicotinic acetylcholine receptor; CRH, corticotropin-releasing hormone; <italic toggle="yes">DEPDC5</italic>, pleckstrin (DEP) domain-containing 5; DNET, dysembryoplastic neuroepithelial tumor; EEG, electroencephalograms; NPD, nocturnal paroxysmal dystonia; EZ, epileptogenic zone; FCD, focal cortical dysplasia; GATOR, GTPase-activating protein activity toward Ras-related GTPases; HMS, hypermotor seizures; <italic toggle="yes">KCNT1</italic>, gene encoding subunit 1 of the sodium-activated potassium channel; LOF, loss-of-function; mMCD, mild malformations of cortical development; mTOR, mammalian target of rapamycin; nAChR, nicotinic acetylcholine receptor; NFLE, nocturnal frontal lobe epilepsy; NPD, nocturnal paroxysmal dystonia; <italic toggle="yes">NPRL</italic>, nitrogen permease regulator-like; NREM, non-rapid eye movement sleep; SEEG, stereoelectroencephalography; SHE, sleep-related hypermotor epilepsy; PAs, paroxysmal arousals; MME, minor motor events; OFC, orbitofrontal cortex; ACC, anterior cingulate cortex; SMA, supplementary motor area; PCC, posterior cingulate cortex; DOA, disorders of arousal; RBD, rapid eye movement sleep behavior disorder; CPGs, central pattern generators; CAP, cyclic alternating pattern; SOZ, seizure onset zone; SP, semiology pattern; VPSG, video polysomnography; CLOCK:circadian locomotor output cycles kaput.</p>
    </sec>
    <sec id="s0010">
      <title>Author Contributions</title>
      <p>All authors contributed to data analysis, drafting or revising the article, have agreed on the journal to which the article will be submitted, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.</p>
    </sec>
    <sec sec-type="COI-statement" id="s0011">
      <title>Disclosure</title>
      <p>The authors declare no conflicts of interest, financial or otherwise.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lugaresi</surname>
<given-names>E</given-names></string-name>. <article-title>Cirignotta F Hypnogenic paroxysmal dystonia: epileptic seizure or a new syndrome?</article-title>
<source><italic toggle="yes">Sleep</italic></source>. <year>1981</year>;<volume>4</volume>(<issue>2</issue>):<fpage>129</fpage>–<lpage>138</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/4.2.129</pub-id><pub-id pub-id-type="pmid">7256073</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lugaresi</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Cirignotta</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Montagna</surname>
<given-names>P</given-names></string-name>. <article-title>Nocturnal paroxysmal dystonia</article-title>. <source><italic toggle="yes">J Neurol Neurosurg Psychiatry</italic></source>. <year>1986</year>;<volume>49</volume>(<issue>4</issue>):<fpage>375</fpage>–<lpage>380</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp.49.4.375</pub-id><pub-id pub-id-type="pmid">2939199</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tinuper</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Cerullo</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cirignotta</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Nocturnal paroxysmal dystonia with short-lasting attacks: three cases with evidence for an epileptic frontal lobe origin of seizures</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>1990</year>;<volume>31</volume>(<issue>5</issue>):<fpage>549</fpage>–<lpage>556</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1157.1990.tb06105.x</pub-id><pub-id pub-id-type="pmid">2401246</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tinuper</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Bisulli</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Cross</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Definition and diagnostic criteria of sleep-related hypermotor epilepsy</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2016</year>;<volume>86</volume>(<issue>19</issue>):<fpage>1834</fpage>–<lpage>1842</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000002666</pub-id><pub-id pub-id-type="pmid">27164717</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gibbs</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Proserpio</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Francione</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Clinical features of sleep-related hypermotor epilepsy in relation to the seizure-onset zone: a review of 135 surgically treated cases</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2019</year>;<volume>60</volume>(<issue>4</issue>):<fpage>707</fpage>–<lpage>717</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.14690</pub-id><pub-id pub-id-type="pmid">30866067</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nobili</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Francione</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mai</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Surgical treatment of drug-resistant nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Brain</italic></source>. <year>2007</year>;<volume>130</volume>(<issue>Pt 2</issue>):<fpage>561</fpage>–<lpage>573</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awl322</pub-id><pub-id pub-id-type="pmid">17124189</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chassoux</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Landre</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mellerio</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Type II focal cortical dysplasia: electroclinical phenotype and surgical outcome related to imaging</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2012</year>;<volume>53</volume>(<issue>2</issue>):<fpage>349</fpage>–<lpage>358</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03363.x</pub-id><pub-id pub-id-type="pmid">22221288</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nobili</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Cardinale</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Magliola</surname>
<given-names>U</given-names></string-name>, et al. <article-title>Taylor’s focal cortical dysplasia increases the risk of sleep-related epilepsy</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2009</year>;<volume>50</volume>(<issue>12</issue>):<fpage>2599</fpage>–<lpage>2604</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2009.02169.x</pub-id><pub-id pub-id-type="pmid">19519797</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Licchetta</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bisulli</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Vignatelli</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Sleep-related hypermotor epilepsy: long-term outcome in a large cohort</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2017</year>;<volume>88</volume>(<issue>1</issue>):<fpage>70</fpage>–<lpage>77</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000003459</pub-id><pub-id pub-id-type="pmid">27881627</pub-id></mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="book"><string-name><surname>Kurahashi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hirose</surname>
<given-names>S</given-names></string-name>, et al. <part-title>Autosomal Dominant Nocturnal Frontal Lobe Epilepsy</part-title>. In: <string-name><surname>Adam</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Ardinger</surname>
<given-names>HH</given-names></string-name>, <string-name><surname>Pagon</surname>
<given-names>RA</given-names></string-name>, editors. <source><italic toggle="yes">GeneReviews((R))</italic></source>. <publisher-name>Seattle (WA)</publisher-name>; <year>1993</year>.</mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Steinlein</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Mulley</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Propping</surname>
<given-names>P</given-names></string-name>, et al. <article-title>A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>1995</year>;<volume>11</volume>(<issue>2</issue>):<fpage>201</fpage>–<lpage>203</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng1095-201</pub-id><pub-id pub-id-type="pmid">7550350</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>De Fusco</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Becchetti</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Patrignani</surname>
<given-names>A</given-names></string-name>, et al. <article-title>The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>2000</year>;<volume>26</volume>(<issue>3</issue>):<fpage>275</fpage>–<lpage>276</lpage>. doi:<pub-id pub-id-type="doi">10.1038/81566</pub-id><pub-id pub-id-type="pmid">11062464</pub-id></mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Aridon</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Marini</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Di Resta</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear</article-title>. <source><italic toggle="yes">Am J Hum Genet</italic></source>. <year>2006</year>;<volume>79</volume>(<issue>2</issue>):<fpage>342</fpage>–<lpage>350</lpage>. doi:<pub-id pub-id-type="doi">10.1086/506459</pub-id><pub-id pub-id-type="pmid">16826524</pub-id></mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Léna</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Popa</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Grailhe</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Beta2-containing nicotinic receptors contribute to the organization of sleep and regulate putative micro-arousals in mice</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2004</year>;<volume>24</volume>(<issue>25</issue>):<fpage>5711</fpage>–<lpage>5718</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3882-03.2004</pub-id><pub-id pub-id-type="pmid">15215293</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Marini</surname>
<given-names>C</given-names></string-name>. <article-title>Guerrini R The role of the nicotinic acetylcholine receptors in sleep-related epilepsy</article-title>. <source><italic toggle="yes">Biochem Pharmacol</italic></source>. <year>2007</year>;<volume>74</volume>(<issue>8</issue>):<fpage>1308</fpage>–<lpage>1314</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bcp.2007.06.030</pub-id><pub-id pub-id-type="pmid">17662253</pub-id></mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Licchetta</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Pippucci</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Baldassari</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Sleep-related hypermotor epilepsy (SHE): contribution of known genes in 103 patients</article-title>. <source><italic toggle="yes">Seizure</italic></source>. <year>2020</year>;<volume>74</volume>:<fpage>60</fpage>–<lpage>64</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.seizure.2019.11.009</pub-id><pub-id pub-id-type="pmid">31835056</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Langenbruch</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Biskup</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>P</given-names></string-name>, et al. <article-title>Two mutations in the nicotinic acetylcholine receptor subunit A4 (CHRNA4) in a family with autosomal dominant sleep-related hypermotor epilepsy</article-title>. <source><italic toggle="yes">Epileptic Disord</italic></source>. <year>2020</year>;<volume>22</volume>(<issue>1</issue>):<fpage>116</fpage>–<lpage>119</lpage>.<pub-id pub-id-type="pmid">32031532</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Phillips</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Favre</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Kirkpatrick</surname>
<given-names>M</given-names></string-name>, et al. <article-title>CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Am J Hum Genet</italic></source>. <year>2001</year>;<volume>68</volume>(<issue>1</issue>):<fpage>225</fpage>–<lpage>231</lpage>. doi:<pub-id pub-id-type="doi">10.1086/316946</pub-id><pub-id pub-id-type="pmid">11104662</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Duga</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Asselta</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bonati</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Mutational analysis of nicotinic acetylcholine receptor beta2 subunit gene (CHRNB2) in a representative cohort of Italian probands affected by autosomal dominant nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2002</year>;<volume>43</volume>(<issue>4</issue>):<fpage>362</fpage>–<lpage>364</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1528-1157.2002.39001.x</pub-id><pub-id pub-id-type="pmid">11952766</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Labate</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mumoli</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Fratto</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Hippocampal sclerosis worsens autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) phenotype related to CHRNB2 mutation</article-title>. <source><italic toggle="yes">Eur j Neurol</italic></source>. <year>2013</year>;<volume>20</volume>(<issue>3</issue>):<fpage>591</fpage>–<lpage>593</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1468-1331.2012.03839.x</pub-id><pub-id pub-id-type="pmid">22897520</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Becchetti</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Grandi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Colombo</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: pathophysiology and Pharmacology</article-title>. <source><italic toggle="yes">Brain Sci</italic></source>. <year>2020</year>;<volume>10</volume>:<fpage>12</fpage>. doi:<pub-id pub-id-type="doi">10.3390/brainsci10120907</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Derry</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Heron</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Phillips</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Severe autosomal dominant nocturnal frontal lobe epilepsy associated with psychiatric disorders and intellectual disability</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2008</year>;<volume>49</volume>(<issue>12</issue>):<fpage>2125</fpage>–<lpage>2129</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01652.x</pub-id><pub-id pub-id-type="pmid">18479385</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lim</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ricos</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Dibbens</surname>
<given-names>L</given-names></string-name>, et al. <article-title>KCNT1 mutations in seizure disorders: the phenotypic spectrum and functional effects</article-title>. <source><italic toggle="yes">J Med Genet</italic></source>. <year>2016</year>;<volume>53</volume>(<issue>4</issue>):<fpage>217</fpage>–<lpage>225</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103508</pub-id><pub-id pub-id-type="pmid">26740507</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Milligan</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gazina</surname>
<given-names>E</given-names></string-name>, et al. <article-title>KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine</article-title>. <source><italic toggle="yes">Ann Neurol</italic></source>. <year>2014</year>;<volume>75</volume>(<issue>4</issue>):<fpage>581</fpage>–<lpage>590</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.24128</pub-id><pub-id pub-id-type="pmid">24591078</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rubboli</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Plazzi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Picard</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Mild malformations of cortical development in sleep-related hypermotor epilepsy due to KCNT1 mutations</article-title>. <source><italic toggle="yes">Ann Clin Transl Neurol</italic></source>. <year>2019</year>;<volume>6</volume>(<issue>2</issue>):<fpage>386</fpage>–<lpage>391</lpage>. doi:<pub-id pub-id-type="doi">10.1002/acn3.708</pub-id><pub-id pub-id-type="pmid">30847371</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Heron</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Bahlo</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>2012</year>;<volume>44</volume>(<issue>11</issue>):<fpage>1188</fpage>–<lpage>1190</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.2440</pub-id><pub-id pub-id-type="pmid">23086396</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Picard</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Makrythanasis</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Navarro</surname>
<given-names>V</given-names></string-name>, et al. <article-title>DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2014</year>;<volume>82</volume>(<issue>23</issue>):<fpage>2101</fpage>–<lpage>2106</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000000488</pub-id><pub-id pub-id-type="pmid">24814846</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dibbens</surname>
<given-names>L</given-names></string-name>, <string-name><surname>de Vries</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Donatello</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Mutations in DEPDC5 cause familial focal epilepsy with variable foci</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>2013</year>;<volume>45</volume>(<issue>5</issue>):<fpage>546</fpage>–<lpage>551</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.2599</pub-id><pub-id pub-id-type="pmid">23542697</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Laplante</surname>
<given-names>M</given-names></string-name>. <article-title>Sabatini D mTOR signaling in growth control and disease</article-title>. <source><italic toggle="yes">Cell</italic></source>. <year>2012</year>;<volume>149</volume>(<issue>2</issue>):<fpage>274</fpage>–<lpage>293</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2012.03.017</pub-id><pub-id pub-id-type="pmid">22500797</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Weckhuysen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Marsan</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Lambrecq</surname>
<given-names>V</given-names></string-name>, et al. <article-title>Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2016</year>;<volume>57</volume>(<issue>6</issue>):<fpage>994</fpage>–<lpage>1003</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.13391</pub-id><pub-id pub-id-type="pmid">27173016</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="book"><string-name><surname>Baulac</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Weckhuysen</surname>
<given-names>S</given-names></string-name>, et al. <part-title>DEPDC5-Related Epilepsy</part-title>. In: <string-name><surname>Adam</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Ardinger</surname>
<given-names>HH</given-names></string-name>, <string-name><surname>Pagon</surname>
<given-names>RA</given-names></string-name>, editors. <source><italic toggle="yes">GeneReviews((R))</italic></source>. <publisher-name>Seattle (WA)</publisher-name>; <year>1993</year>.</mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lim</surname>
<given-names>KC</given-names></string-name>. <article-title>Crino PB Focal malformations of cortical development: new vistas for molecular pathogenesis</article-title>. <source><italic toggle="yes">Neuroscience</italic></source>. <year>2013</year>;<volume>252</volume>:<fpage>262</fpage>–<lpage>276</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.07.037</pub-id><pub-id pub-id-type="pmid">23892008</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Baldassari</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Picard</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Verbeek</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Correction: the landscape of epilepsy-related GATOR1 variants</article-title>. <source><italic toggle="yes">Genetics Med</italic></source>. <year>2019</year>;<volume>21</volume>(<issue>8</issue>):<fpage>1896</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41436-018-0325-9</pub-id><pub-id pub-id-type="pmid">30262923</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Pippucci</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Licchetta</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Baldassari</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Contribution of ultrarare variants in mTOR pathway genes to sporadic focal epilepsies</article-title>. <source><italic toggle="yes">Ann Clin Translational Neurol</italic></source>. <year>2019</year>;<volume>6</volume>(<issue>3</issue>):<fpage>475</fpage>–<lpage>485</lpage>. doi:<pub-id pub-id-type="doi">10.1002/acn3.722</pub-id></mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ricos</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hodgson</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Pippucci</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy</article-title>. <source><italic toggle="yes">Ann Neurol</italic></source>. <year>2016</year>;<volume>79</volume>(<issue>1</issue>):<fpage>120</fpage>–<lpage>131</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.24547</pub-id><pub-id pub-id-type="pmid">26505888</pub-id></mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Combi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Dalprà</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ferini-Strambi</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Frontal lobe epilepsy and mutations of the corticotropin-releasing hormone gene</article-title>. <source><italic toggle="yes">Ann Neurol</italic></source>. <year>2005</year>;<volume>58</volume>(<issue>6</issue>):<fpage>899</fpage>–<lpage>904</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.20660</pub-id><pub-id pub-id-type="pmid">16222669</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sansoni</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Forcella</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mozzi</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Functional characterization of a CRH missense mutation identified in an ADNFLE family</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2013</year>;<volume>8</volume>(<issue>4</issue>):<fpage>e61306</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0061306</pub-id><pub-id pub-id-type="pmid">23593457</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Adzhubei</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Schmidt</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Peshkin</surname>
<given-names>L</given-names></string-name>, et al. <article-title>A method and server for predicting damaging missense mutations</article-title>. <source><italic toggle="yes">Nat Methods</italic></source>. <year>2010</year>;<volume>7</volume>(<issue>4</issue>):<fpage>248</fpage>–<lpage>249</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id><pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ferini-Strambi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Sansoni</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Combi</surname>
<given-names>R</given-names></string-name>. <article-title>Nocturnal frontal lobe epilepsy and the acetylcholine receptor</article-title>. <source><italic toggle="yes">neurologist</italic></source>. <year>2012</year>;<volume>18</volume>(<issue>6</issue>):<fpage>343</fpage>–<lpage>349</lpage>. doi:<pub-id pub-id-type="doi">10.1097/NRL.0b013e31826a99b8</pub-id><pub-id pub-id-type="pmid">23114665</pub-id></mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hildebrand</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tankard</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gazina</surname>
<given-names>E</given-names></string-name>, et al. <article-title>PRIMA1 mutation: a new cause of nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Ann Clin Translational Neurol</italic></source>. <year>2015</year>;<volume>2</volume>(<issue>8</issue>):<fpage>821</fpage>–<lpage>830</lpage>. doi:<pub-id pub-id-type="doi">10.1002/acn3.224</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zhuo</surname>
<given-names>M</given-names></string-name>, et al. <article-title>CABP4Exome sequencing identified a novel missense mutation c.464G&gt;A (p.G155D) in Ca-binding protein 4 () in a Chinese pedigree with autosomal dominant nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Oncotarget</italic></source>. <year>2017</year>;<volume>8</volume>(<issue>45</issue>):<fpage>78940</fpage>–<lpage>78947</lpage>. doi:<pub-id pub-id-type="doi">10.18632/oncotarget.20694</pub-id><pub-id pub-id-type="pmid">29108277</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Peres</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Antunes</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Zonjy</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Sleep-related hypermotor epilepsy and peri-ictal hypotension in a patient with syntaxin-1B mutation</article-title>. <source><italic toggle="yes">Epileptic Disorders</italic></source>. <year>2018</year>;<volume>20</volume>(<issue>5</issue>):<fpage>413</fpage>–<lpage>417</lpage>. doi:<pub-id pub-id-type="doi">10.1684/epd.2018.0996</pub-id><pub-id pub-id-type="pmid">30378543</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mastrangelo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Commone</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Greco</surname>
<given-names>C</given-names></string-name>, et al. <article-title>TSC1 as a Novel Gene for Sleep-Related Hypermotor Epilepsy: a Child with a Mild Phenotype of Tuberous Sclerosis</article-title>. <source><italic toggle="yes">Neuropediatrics</italic></source>. <year>2021</year>;<volume>52</volume>(<issue>2</issue>):<fpage>146</fpage>–<lpage>149</lpage>. doi:<pub-id pub-id-type="doi">10.1055/s-0041-1722881</pub-id><pub-id pub-id-type="pmid">33578443</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Loss of CLOCK Results in Dysfunction of Brain Circuits Underlying Focal Epilepsy</article-title>. <source><italic toggle="yes">Neuron</italic></source>. <year>2017</year>;<volume>96</volume>(<issue>2</issue>):<fpage>387</fpage>–<lpage>401.e6</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuron.2017.09.044</pub-id><pub-id pub-id-type="pmid">29024662</pub-id></mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Vignatelli</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bisulli</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Giovannini</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Prevalence of nocturnal frontal lobe epilepsy in the adult population of Bologna and Modena, Emilia-Romagna region, Italy</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2015</year>;<volume>38</volume>(<issue>3</issue>):<fpage>479</fpage>–<lpage>485</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.4514</pub-id><pub-id pub-id-type="pmid">25406112</pub-id></mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Provini</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Plazzi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Tinuper</surname>
<given-names>P</given-names></string-name>, et al. <article-title>Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases</article-title>. <source><italic toggle="yes">Brain</italic></source>. <year>1999</year>;<volume>122</volume>(<issue>Pt 6</issue>):<fpage>1017</fpage>–<lpage>1031</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/122.6.1017</pub-id><pub-id pub-id-type="pmid">10356056</pub-id></mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Scheffer</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Bhatia</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Lopes-Cendes</surname>
<given-names>I</given-names></string-name>. et al. <article-title>Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder</article-title>. <source><italic toggle="yes">Brain</italic></source>;<year>1995</year>. <fpage>61</fpage>–<lpage>73</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/118.1.61</pub-id><pub-id pub-id-type="pmid">7895015</pub-id></mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Menghi</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Bisulli</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Tinuper</surname>
<given-names>P</given-names></string-name>, et al. <article-title>Sleep-related hypermotor epilepsy: prevalence, impact and management strategies</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2018</year>;<volume>10</volume>:<fpage>317</fpage>–<lpage>326</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S152624</pub-id><pub-id pub-id-type="pmid">30349413</pub-id></mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bisulli</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Vignatelli</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Naldi</surname>
<given-names>I</given-names></string-name>, et al. <article-title>Increased frequency of arousal parasomnias in families with nocturnal frontal lobe epilepsy: a common mechanism?</article-title>
<source><italic toggle="yes">Epilepsia</italic></source>. <year>2010</year>;<volume>51</volume>(<issue>9</issue>):<fpage>1852</fpage>–<lpage>1860</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02581.x</pub-id><pub-id pub-id-type="pmid">20477848</pub-id></mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bisulli</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Vignatelli</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Naldi</surname>
<given-names>I</given-names></string-name>, et al. <article-title>Diagnostic accuracy of a structured interview for nocturnal frontal lobe epilepsy (SINFLE): a proposal for developing diagnostic criteria</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2012</year>;<volume>13</volume>(<issue>1</issue>):<fpage>81</fpage>–<lpage>87</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2011.09.003</pub-id><pub-id pub-id-type="pmid">22137114</pub-id></mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jobst</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Siegel</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Thadani</surname>
<given-names>V</given-names></string-name>, et al. <article-title>Intractable seizures of frontal lobe origin: clinical characteristics, localizing signs, and results of surgery</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2000</year>;<volume>41</volume>(<issue>9</issue>):<fpage>1139</fpage>–<lpage>1152</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1157.2000.tb00319.x</pub-id><pub-id pub-id-type="pmid">10999553</pub-id></mixed-citation>
      </ref>
      <ref id="cit0052">
        <label>52.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rheims</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ryvlin</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Scherer</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Analysis of clinical patterns and underlying epileptogenic zones of hypermotor seizures</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2008</year>;<volume>49</volume>(<issue>12</issue>):<fpage>2030</fpage>–<lpage>2040</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01675.x</pub-id><pub-id pub-id-type="pmid">18503559</pub-id></mixed-citation>
      </ref>
      <ref id="cit0053">
        <label>53.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Terzaghi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sartori</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Mai</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Sleep-related minor motor events in nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2007</year>;<volume>48</volume>(<issue>2</issue>):<fpage>335</fpage>–<lpage>341</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2006.00929.x</pub-id><pub-id pub-id-type="pmid">17295628</pub-id></mixed-citation>
      </ref>
      <ref id="cit0054">
        <label>54.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nobili</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Sartori</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Terzaghi</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Intracerebral recordings of minor motor events, paroxysmal arousals and major seizures in nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Neurol Sci</italic></source>. <year>2005</year>;<volume>26</volume>(<issue>Suppl 3</issue>):<fpage>s215</fpage>–<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10072-005-0490-x</pub-id></mixed-citation>
      </ref>
      <ref id="cit0055">
        <label>55.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Parrino</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Halasz</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Tassinari</surname>
<given-names>C</given-names></string-name>, et al. <article-title>CAP, epilepsy and motor events during sleep: the unifying role of arousal</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2006</year>;<volume>10</volume>(<issue>4</issue>):<fpage>267</fpage>–<lpage>285</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2005.12.004</pub-id><pub-id pub-id-type="pmid">16809057</pub-id></mixed-citation>
      </ref>
      <ref id="cit0056">
        <label>56.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gibbs</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Proserpio</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Terzaghi</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Sleep-related epileptic behaviors and non-REM-related parasomnias: insights from stereo-EEG</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2016</year>;<volume>25</volume>:<fpage>4</fpage>–<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2015.05.002</pub-id><pub-id pub-id-type="pmid">26164370</pub-id></mixed-citation>
      </ref>
      <ref id="cit0057">
        <label>57.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sforza</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Montagna</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Rinaldi</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Paroxysmal periodic motor attacks during sleep: clinical and polygraphic features</article-title>. <source><italic toggle="yes">Electroencephalogr Clin Neurophysiol</italic></source>. <year>1993</year>;<volume>86</volume>(<issue>3</issue>):<fpage>161</fpage>–<lpage>166</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0013-4694(93)90003-E</pub-id><pub-id pub-id-type="pmid">7680991</pub-id></mixed-citation>
      </ref>
      <ref id="cit0058">
        <label>58.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nobili</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Francione</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mai</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Nocturnal frontal lobe epilepsy: intracerebral recordings of paroxysmal motor attacks with increasing complexity</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2003</year>;<volume>26</volume>(<issue>7</issue>):<fpage>883</fpage>–<lpage>886</lpage>.<pub-id pub-id-type="pmid">14655924</pub-id></mixed-citation>
      </ref>
      <ref id="cit0059">
        <label>59.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nobili</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Proserpio</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Combi</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Curr Neurol Neurosci Rep</italic></source>. <year>2014</year>;<volume>14</volume>(<issue>2</issue>):<fpage>424</fpage>. doi:<pub-id pub-id-type="doi">10.1007/s11910-013-0424-6</pub-id><pub-id pub-id-type="pmid">24395520</pub-id></mixed-citation>
      </ref>
      <ref id="cit0060">
        <label>60.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nobili</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Cossu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mai</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Sleep-related hyperkinetic seizures of temporal lobe origin</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2004</year>;<volume>62</volume>(<issue>3</issue>):<fpage>482</fpage>–<lpage>485</lpage>. doi:<pub-id pub-id-type="doi">10.1212/01.WNL.0000106945.68292.DC</pub-id><pub-id pub-id-type="pmid">14872038</pub-id></mixed-citation>
      </ref>
      <ref id="cit0061">
        <label>61.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Proserpio</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Cossu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Francione</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Epileptic motor behaviors during sleep: anatomo-electro-clinical features</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2011</year>;<volume>12</volume>(<issue>Suppl 2</issue>):<fpage>S33</fpage>–<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2011.10.018</pub-id><pub-id pub-id-type="pmid">22136897</pub-id></mixed-citation>
      </ref>
      <ref id="cit0062">
        <label>62.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gibbs</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Figorilli</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Casaceli</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Sleep Related Hypermotor Seizures with a Right Parietal Onset</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2015</year>;<volume>11</volume>(<issue>8</issue>):<fpage>953</fpage>–<lpage>955</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.4952</pub-id><pub-id pub-id-type="pmid">25902821</pub-id></mixed-citation>
      </ref>
      <ref id="cit0063">
        <label>63.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nobili</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Francione</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Cardinale</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Epileptic nocturnal wanderings with a temporal lobe origin: a stereo-electroencephalographic study</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2002</year>;<volume>25</volume>(<issue>6</issue>):<fpage>669</fpage>–<lpage>671</lpage>.<pub-id pub-id-type="pmid">12224845</pub-id></mixed-citation>
      </ref>
      <ref id="cit0064">
        <label>64.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ryvlin</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Minotti</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Demarquay</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Nocturnal hypermotor seizures, suggesting frontal lobe epilepsy, can originate in the insula</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2006</year>;<volume>47</volume>(<issue>4</issue>):<fpage>755</fpage>–<lpage>765</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2006.00510.x</pub-id><pub-id pub-id-type="pmid">16650142</pub-id></mixed-citation>
      </ref>
      <ref id="cit0065">
        <label>65.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ferri</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bisulli</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Mai</surname>
<given-names>R</given-names></string-name>, et al. <article-title>A stereo EEG study in a patient with sleep-related hypermotor epilepsy due to DEPDC5 mutation</article-title>. <source><italic toggle="yes">Seizure</italic></source>. <year>2017</year>;<volume>53</volume>:<fpage>51</fpage>–<lpage>54</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.seizure.2017.10.022</pub-id><pub-id pub-id-type="pmid">29125946</pub-id></mixed-citation>
      </ref>
      <ref id="cit0066">
        <label>66.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dobesberger</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ortler</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Unterberger</surname>
<given-names>I</given-names></string-name>, et al. <article-title>Successful surgical treatment of insular epilepsy with nocturnal hypermotor seizures</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2008</year>;<volume>49</volume>(<issue>1</issue>):<fpage>159</fpage>–<lpage>162</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01426.x</pub-id><pub-id pub-id-type="pmid">18028409</pub-id></mixed-citation>
      </ref>
      <ref id="cit0067">
        <label>67.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Steinlein</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Hoda</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bertrand</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Mutations in familial nocturnal frontal lobe epilepsy might be associated with distinct neurological phenotypes</article-title>. <source><italic toggle="yes">Seizure</italic></source>. <year>2012</year>;<volume>21</volume>(<issue>2</issue>):<fpage>118</fpage>–<lpage>123</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.seizure.2011.10.003</pub-id><pub-id pub-id-type="pmid">22036597</pub-id></mixed-citation>
      </ref>
      <ref id="cit0068">
        <label>68.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Conti</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Aracri</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Chiti</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2015</year>;<volume>84</volume>(<issue>15</issue>):<fpage>1520</fpage>–<lpage>1528</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000001471</pub-id><pub-id pub-id-type="pmid">25770198</pub-id></mixed-citation>
      </ref>
      <ref id="cit0069">
        <label>69.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Picard</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Pegna</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Arntsberg</surname>
<given-names>V</given-names></string-name>, et al. <article-title>Neuropsychological disturbances in frontal lobe epilepsy due to mutated nicotinic receptors</article-title>. <source><italic toggle="yes">Epilepsy Behav</italic></source>. <year>2009</year>;<volume>14</volume>(<issue>2</issue>):<fpage>354</fpage>–<lpage>359</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yebeh.2008.11.003</pub-id><pub-id pub-id-type="pmid">19059498</pub-id></mixed-citation>
      </ref>
      <ref id="cit0070">
        <label>70.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wood</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Saling</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fedi</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Neuropsychological function in patients with a single gene mutation associated with autosomal dominant nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Epilepsy Behav</italic></source>. <year>2010</year>;<volume>17</volume>(<issue>4</issue>):<fpage>531</fpage>–<lpage>535</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yebeh.2010.01.168</pub-id><pub-id pub-id-type="pmid">20189461</pub-id></mixed-citation>
      </ref>
      <ref id="cit0071">
        <label>71.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Licchetta</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Poda</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Vignatelli</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Profile of neuropsychological impairment in Sleep-related Hypermotor Epilepsy</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2018</year>;<volume>48</volume>:<fpage>8</fpage>–<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2018.03.027</pub-id><pub-id pub-id-type="pmid">29843024</pub-id></mixed-citation>
      </ref>
      <ref id="cit0072">
        <label>72.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Baldassari</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Picard</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Verbeek</surname>
<given-names>N</given-names></string-name>, et al. <article-title>The landscape of epilepsy-related GATOR1 variants</article-title>. <source><italic toggle="yes">Genetics Med</italic></source>. <year>2019</year>;<volume>21</volume>(<issue>2</issue>):<fpage>398</fpage>–<lpage>408</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41436-018-0060-2</pub-id><pub-id pub-id-type="pmid">30093711</pub-id></mixed-citation>
      </ref>
      <ref id="cit0073">
        <label>73.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fukuyama</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Fukuzawa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Okubo</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Upregulated Connexin 43 Induced by Loss-of-Functional S284L-Mutant alpha4 Subunit of Nicotinic ACh Receptor Contributes to Pathomechanisms of Autosomal Dominant Sleep-Related Hypermotor Epilepsy</article-title>. <source><italic toggle="yes">Pharmaceuticals</italic></source>. <year>2020</year>;<volume>13</volume>:<fpage>4</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0074">
        <label>74.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fukuyama</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Fukuzawa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shiroyama</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Pathogenesis and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant alpha4 subunit of nicotinic ACh receptor</article-title>. <source><italic toggle="yes">Br J Pharmacol</italic></source>. <year>2020</year>;<volume>177</volume>(<issue>9</issue>):<fpage>2143</fpage>–<lpage>2162</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bph.14974</pub-id><pub-id pub-id-type="pmid">31901135</pub-id></mixed-citation>
      </ref>
      <ref id="cit0075">
        <label>75.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fukuyama</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Fukuzawa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shiroyama</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Pathomechanism of nocturnal paroxysmal dystonia in autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant α4 subunit of nicotinic ACh receptor</article-title>. <source><italic toggle="yes">Biomed Pharmacotherapy</italic></source>. <year>2020</year>;<volume>126</volume>:<fpage>110070</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopha.2020.110070</pub-id></mixed-citation>
      </ref>
      <ref id="cit0076">
        <label>76.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fukuyama</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Fukuzawa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Okada</surname>
<given-names>M</given-names></string-name>. <article-title>Upregulated and Hyperactivated Thalamic Connexin 43 Plays Important Roles in Pathomechanisms of Cognitive Impairment and Seizure of Autosomal Dominant Sleep-Related Hypermotor Epilepsy with S284L-Mutant α4 Subunit of Nicotinic ACh Receptor</article-title>. <source><italic toggle="yes">Pharmaceuticals</italic></source>. <year>2020</year>;<volume>13</volume>(<issue>5</issue>):<fpage>548</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0077">
        <label>77.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schonauer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Alizadeh</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jamalabadi</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Decoding material-specific memory reprocessing during sleep in humans</article-title>. <source><italic toggle="yes">Nat Commun</italic></source>. <year>2017</year>;<volume>8</volume>:<fpage>15404</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ncomms15404</pub-id><pub-id pub-id-type="pmid">28513589</pub-id></mixed-citation>
      </ref>
      <ref id="cit0078">
        <label>78.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chakravarty</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Shukla</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Poornima</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Effect of sleep quality on memory, executive function, and language performance in patients with refractory focal epilepsy and controlled epilepsy versus healthy controls - A prospective study</article-title>. <source><italic toggle="yes">Epilepsy Behav</italic></source>. <year>2019</year>;<volume>92</volume>:<fpage>176</fpage>–<lpage>183</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yebeh.2018.12.028</pub-id><pub-id pub-id-type="pmid">30665125</pub-id></mixed-citation>
      </ref>
      <ref id="cit0079">
        <label>79.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ampuero</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Dagnino-Subiabre</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sandoval</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Status epilepticus induces region-specific changes in dendritic spines, dendritic length and TrkB protein content of rat brain cortex</article-title>. <source><italic toggle="yes">Brain Res</italic></source>. <year>2007</year>;<volume>1150</volume>:<fpage>225</fpage>–<lpage>238</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.brainres.2007.02.089</pub-id><pub-id pub-id-type="pmid">17397806</pub-id></mixed-citation>
      </ref>
      <ref id="cit0080">
        <label>80.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bartolomei</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Lagarde</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wendling</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Defining epileptogenic networks: contribution of SEEG and signal analysis</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2017</year>;<volume>58</volume>(<issue>7</issue>):<fpage>1131</fpage>–<lpage>1147</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.13791</pub-id><pub-id pub-id-type="pmid">28543030</pub-id></mixed-citation>
      </ref>
      <ref id="cit0081">
        <label>81.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chauvel</surname>
<given-names>P</given-names></string-name>. <article-title>McGonigal A Emergence of semiology in epileptic seizures</article-title>. <source><italic toggle="yes">Epilepsy Behav</italic></source>. <year>2014</year>;<volume>38</volume>:<fpage>94</fpage>–<lpage>103</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yebeh.2013.12.003</pub-id><pub-id pub-id-type="pmid">24424286</pub-id></mixed-citation>
      </ref>
      <ref id="cit0082">
        <label>82.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tufenkjian</surname>
<given-names>K</given-names></string-name>. <article-title>Luders HO Seizure semiology: its value and limitations in localizing the epileptogenic zone</article-title>. <source><italic toggle="yes">J Clin Neurol</italic></source>. <year>2012</year>;<volume>8</volume>(<issue>4</issue>):<fpage>243</fpage>–<lpage>250</lpage>. doi:<pub-id pub-id-type="doi">10.3988/jcn.2012.8.4.243</pub-id><pub-id pub-id-type="pmid">23323131</pub-id></mixed-citation>
      </ref>
      <ref id="cit0083">
        <label>83.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rosenow</surname>
<given-names>F</given-names></string-name>. <article-title>Lüders H Presurgical evaluation of epilepsy</article-title>. <source><italic toggle="yes">Brain</italic></source>. <year>2001</year>;<volume>124</volume>:<fpage>1683</fpage>–<lpage>1700</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/124.9.1683</pub-id><pub-id pub-id-type="pmid">11522572</pub-id></mixed-citation>
      </ref>
      <ref id="cit0084">
        <label>84.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lüders</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Najm</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Nair</surname>
<given-names>D</given-names></string-name>, et al. <article-title>The epileptogenic zone: general principles</article-title>. <source><italic toggle="yes">Epileptic Disorders</italic></source>. <year>2006</year>;<volume>1</volume>:<fpage>S1</fpage>–<lpage>9</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0085">
        <label>85.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lüders</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Acharya</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Baumgartner</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Semiological seizure classification</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>1998</year>;<volume>39</volume>(<issue>9</issue>):<fpage>1006</fpage>–<lpage>1013</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1157.1998.tb01452.x</pub-id><pub-id pub-id-type="pmid">9738682</pub-id></mixed-citation>
      </ref>
      <ref id="cit0086">
        <label>86.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Foldvary-Schaefer</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Unnwongse</surname>
<given-names>K</given-names></string-name>. <article-title>Localizing and lateralizing features of auras and seizures</article-title>. <source><italic toggle="yes">Epilepsy Behav</italic></source>. <year>2011</year>;<volume>20</volume>(<issue>2</issue>):<fpage>160</fpage>–<lpage>166</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yebeh.2010.08.034</pub-id><pub-id pub-id-type="pmid">20926350</pub-id></mixed-citation>
      </ref>
      <ref id="cit0087">
        <label>87.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yin</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ni</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Auras in intractable frontal lobe epilepsy: clinical characteristics, values, and limitations</article-title>. <source><italic toggle="yes">Epilepsy Behav</italic></source>. <year>2021</year>;<volume>115</volume>:<fpage>107724</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yebeh.2020.107724</pub-id><pub-id pub-id-type="pmid">33423014</pub-id></mixed-citation>
      </ref>
      <ref id="cit0088">
        <label>88.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Blume</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Lüders</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Mizrahi</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2001</year>;<volume>42</volume>(<issue>9</issue>):<fpage>1212</fpage>–<lpage>1218</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1528-1157.2001.22001.x</pub-id><pub-id pub-id-type="pmid">11580774</pub-id></mixed-citation>
      </ref>
      <ref id="cit0089">
        <label>89.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Montavont</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kahane</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Catenoix</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Hypermotor seizures in lateral and mesial parietal epilepsy</article-title>. <source><italic toggle="yes">Epilepsy Behav</italic></source>. <year>2013</year>;<volume>28</volume>(<issue>3</issue>):<fpage>408</fpage>–<lpage>412</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yebeh.2013.05.030</pub-id><pub-id pub-id-type="pmid">23872083</pub-id></mixed-citation>
      </ref>
      <ref id="cit0090">
        <label>90.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bonini</surname>
<given-names>F</given-names></string-name>, <string-name><surname>McGonigal</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Trebuchon</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Frontal lobe seizures: from clinical semiology to localization</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2014</year>;<volume>55</volume>(<issue>2</issue>):<fpage>264</fpage>–<lpage>277</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.12490</pub-id><pub-id pub-id-type="pmid">24372328</pub-id></mixed-citation>
      </ref>
      <ref id="cit0091">
        <label>91.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fayerstein</surname>
<given-names>J</given-names></string-name>, <string-name><surname>McGonigal</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pizzo</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Quantitative analysis of hyperkinetic seizures and correlation with seizure onset zone</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2020</year>;<volume>61</volume>(<issue>5</issue>):<fpage>1019</fpage>–<lpage>1026</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.16510</pub-id><pub-id pub-id-type="pmid">32378738</pub-id></mixed-citation>
      </ref>
      <ref id="cit0092">
        <label>92.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Davidson</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Putnam</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Larson</surname>
<given-names>C</given-names></string-name>. <article-title>Dysfunction in the neural circuitry of emotion regulation–a possible prelude to violence</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2000</year>;<volume>289</volume>(<issue>5479</issue>):<fpage>591</fpage>–<lpage>594</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.289.5479.591</pub-id><pub-id pub-id-type="pmid">10915615</pub-id></mixed-citation>
      </ref>
      <ref id="cit0093">
        <label>93.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bartolomei</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Trebuchon</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gavaret</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Acute alteration of emotional behaviour in epileptic seizures is related to transient desynchrony in emotion-regulation networks</article-title>. <source><italic toggle="yes">Clin Neurophysiol</italic></source>. <year>2005</year>;<volume>116</volume>(<issue>10</issue>):<fpage>2473</fpage>–<lpage>2479</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clinph.2005.05.013</pub-id><pub-id pub-id-type="pmid">16125458</pub-id></mixed-citation>
      </ref>
      <ref id="cit0094">
        <label>94.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Mathews</surname>
<given-names>GC</given-names></string-name>, <string-name><surname>Whetsell</surname>
<given-names>WO</given-names></string-name>, et al. <article-title>Hypermotor seizures in patients with temporal pole lesions</article-title>. <source><italic toggle="yes">Epilepsy Res</italic></source>. <year>2008</year>;<volume>82</volume>(<issue>1</issue>):<fpage>93</fpage>–<lpage>98</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2008.07.005</pub-id><pub-id pub-id-type="pmid">18760904</pub-id></mixed-citation>
      </ref>
      <ref id="cit0095">
        <label>95.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Staack</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bilic</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wendling</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Hyperkinetic seizures in patients with temporal lobe epilepsy: clinical features and outcome after temporal lobe resection</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2011</year>;<volume>52</volume>(<issue>8</issue>):<fpage>1439</fpage>–<lpage>1446</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03100.x</pub-id><pub-id pub-id-type="pmid">21569022</pub-id></mixed-citation>
      </ref>
      <ref id="cit0096">
        <label>96.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nitta</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Usui</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Kondo</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Semiology of hyperkinetic seizures of frontal versus temporal lobe origin</article-title>. <source><italic toggle="yes">Epileptic Disord</italic></source>. <year>2019</year>;<volume>21</volume>(<issue>2</issue>):<fpage>154</fpage>–<lpage>165</lpage>.<pub-id pub-id-type="pmid">31010798</pub-id></mixed-citation>
      </ref>
      <ref id="cit0097">
        <label>97.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Vaugier</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Aubert</surname>
<given-names>S</given-names></string-name>, <string-name><surname>McGonigal</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Neural networks underlying hyperkinetic seizures of “temporal lobe” origin</article-title>. <source><italic toggle="yes">Epilepsy Res</italic></source>. <year>2009</year>;<volume>86</volume>(<issue>2–3</issue>):<fpage>200</fpage>–<lpage>208</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2009.06.007</pub-id><pub-id pub-id-type="pmid">19619985</pub-id></mixed-citation>
      </ref>
      <ref id="cit0098">
        <label>98.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nguyen</surname>
<given-names>DK</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Malak</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Revisiting the role of the insula in refractory partial epilepsy</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2009</year>;<volume>50</volume>(<issue>3</issue>):<fpage>510</fpage>–<lpage>520</lpage>.<pub-id pub-id-type="pmid">18717706</pub-id></mixed-citation>
      </ref>
      <ref id="cit0099">
        <label>99.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Proserpio</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Cossu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Francione</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Insular-opercular seizures manifesting with sleep-related paroxysmal motor behaviors: a stereo-EEG study</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2011</year>;<volume>52</volume>(<issue>10</issue>):<fpage>1781</fpage>–<lpage>1791</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03254.x</pub-id><pub-id pub-id-type="pmid">21883183</pub-id></mixed-citation>
      </ref>
      <ref id="cit0100">
        <label>100.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Klein</surname>
<given-names>TA</given-names></string-name>, <string-name><surname>Ullsperger</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Danielmeier</surname>
<given-names>C</given-names></string-name>. <article-title>Error awareness and the insula: links to neurological and psychiatric diseases</article-title>. <source><italic toggle="yes">Front Hum Neurosci</italic></source>. <year>2013</year>;<volume>7</volume>:<fpage>14</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnhum.2013.00014</pub-id><pub-id pub-id-type="pmid">23382714</pub-id></mixed-citation>
      </ref>
      <ref id="cit0101">
        <label>101.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kurth</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Zilles</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Fox</surname>
<given-names>PT</given-names></string-name>, et al. <article-title>A link between the systems: functional differentiation and integration within the human insula revealed by meta-analysis</article-title>. <source><italic toggle="yes">Brain Struct Funct</italic></source>. <year>2010</year>;<volume>214</volume>(<issue>5–6</issue>):<fpage>519</fpage>–<lpage>534</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00429-010-0255-z</pub-id><pub-id pub-id-type="pmid">20512376</pub-id></mixed-citation>
      </ref>
      <ref id="cit0102">
        <label>102.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>McGonigal</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Semiologic subgroups of insulo-opercular seizures based on connectional architecture atlas</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2020</year>;<volume>61</volume>(<issue>5</issue>):<fpage>984</fpage>–<lpage>994</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.16501</pub-id><pub-id pub-id-type="pmid">32314372</pub-id></mixed-citation>
      </ref>
      <ref id="cit0103">
        <label>103.</label>
        <mixed-citation publication-type="book"><string-name><surname>Nieuwenhuys</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Voogd</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Van Huijzen</surname>
<given-names>C</given-names></string-name>. <source><italic toggle="yes">The Human Central Nervous System</italic></source>. <publisher-name>Springer Science &amp; Business Media</publisher-name>; <year>2008</year>.</mixed-citation>
      </ref>
      <ref id="cit0104">
        <label>104.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fluchere</surname>
<given-names>F</given-names></string-name>, <string-name><surname>McGonigal</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Villeneuve</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Ictal “hemiballic-like” movement: lateralizing and localizing value</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2012</year>;<volume>53</volume>(<issue>2</issue>):<fpage>e41</fpage>–<lpage>5</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03362.x</pub-id><pub-id pub-id-type="pmid">22191383</pub-id></mixed-citation>
      </ref>
      <ref id="cit0105">
        <label>105.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bartolomei</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Gavaret</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hewett</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Neural networks underlying parietal lobe seizures: a quantified study from intracerebral recordings</article-title>. <source><italic toggle="yes">Epilepsy Res</italic></source>. <year>2011</year>;<volume>93</volume>(<issue>2–3</issue>):<fpage>164</fpage>–<lpage>176</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2010.12.005</pub-id><pub-id pub-id-type="pmid">21227653</pub-id></mixed-citation>
      </ref>
      <ref id="cit0106">
        <label>106.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rushworth</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Behrens</surname>
<given-names>TE</given-names></string-name>, <string-name><surname>Johansen-Berg</surname>
<given-names>H</given-names></string-name>. <article-title>Connection patterns distinguish 3 regions of human parietal cortex</article-title>. <source><italic toggle="yes">Cereb Cortex</italic></source>. <year>2006</year>;<volume>16</volume>(<issue>10</issue>):<fpage>1418</fpage>–<lpage>1430</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cercor/bhj079</pub-id><pub-id pub-id-type="pmid">16306320</pub-id></mixed-citation>
      </ref>
      <ref id="cit0107">
        <label>107.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gibbs</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Proserpio</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Francione</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Seizure duration and latency of hypermotor manifestations distinguish frontal from extrafrontal onset in sleep-related hypermotor epilepsy</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2018</year>;<volume>59</volume>(<issue>9</issue>):<fpage>e130</fpage>–<lpage>e134</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.14517</pub-id><pub-id pub-id-type="pmid">30009443</pub-id></mixed-citation>
      </ref>
      <ref id="cit0108">
        <label>108.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sateia</surname>
<given-names>MJ</given-names></string-name>. <article-title>International Classification of Sleep Disorders-Third Edition</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2014</year>;<volume>146</volume>(<issue>5</issue>):<fpage>1387</fpage>–<lpage>1394</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.14-0970</pub-id><pub-id pub-id-type="pmid">25367475</pub-id></mixed-citation>
      </ref>
      <ref id="cit0109">
        <label>109.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schenck</surname>
<given-names>C</given-names></string-name>. <article-title>Mahowald M REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2002</year>;<volume>25</volume>(<issue>2</issue>):<fpage>120</fpage>–<lpage>138</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/25.2.120</pub-id><pub-id pub-id-type="pmid">11902423</pub-id></mixed-citation>
      </ref>
      <ref id="cit0110">
        <label>110.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fernández-Arcos</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Iranzo</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Serradell</surname>
<given-names>M</given-names></string-name>, et al. <article-title>The Clinical Phenotype of Idiopathic Rapid Eye Movement Sleep Behavior Disorder at Presentation: a Study in 203 Consecutive Patients</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2016</year>;<volume>39</volume>(<issue>1</issue>):<fpage>121</fpage>–<lpage>132</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.5332</pub-id><pub-id pub-id-type="pmid">26940460</pub-id></mixed-citation>
      </ref>
      <ref id="cit0111">
        <label>111.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zucconi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Oldani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ferini-Strambi</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Nocturnal paroxysmal arousals with motor behaviors during sleep: frontal lobe epilepsy or parasomnia?</article-title>
<source><italic toggle="yes">J Clin Neurophysiol</italic></source>. <year>1997</year>;<volume>14</volume>(<issue>6</issue>):<fpage>513</fpage>–<lpage>522</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00004691-199711000-00008</pub-id><pub-id pub-id-type="pmid">9458058</pub-id></mixed-citation>
      </ref>
      <ref id="cit0112">
        <label>112.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Montini</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Loddo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Baldelli</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Sleep-Related Hypermotor Epilepsy vs Disorders of Arousal in Adults: a Step-Wise Approach to Diagnosis</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2021</year>;<volume>160</volume>(<issue>1</issue>):<fpage>319</fpage>–<lpage>329</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2021.01.059</pub-id><pub-id pub-id-type="pmid">33529771</pub-id></mixed-citation>
      </ref>
      <ref id="cit0113">
        <label>113.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Breen</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Högl</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Fasano</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Sleep-related motor and behavioral disorders: recent advances and new entities</article-title>. <source><italic toggle="yes">Movement Disorders</italic></source>. <year>2018</year>;<volume>33</volume>(<issue>7</issue>):<fpage>1042</fpage>–<lpage>1055</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.27375</pub-id><pub-id pub-id-type="pmid">29756278</pub-id></mixed-citation>
      </ref>
      <ref id="cit0114">
        <label>114.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Derry</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Davey</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Johns</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Distinguishing sleep disorders from seizures: diagnosing bumps in the night</article-title>. <source><italic toggle="yes">Arch Neurol</italic></source>. <year>2006</year>;<volume>63</volume>(<issue>5</issue>):<fpage>705</fpage>–<lpage>709</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archneur.63.5.705</pub-id><pub-id pub-id-type="pmid">16682539</pub-id></mixed-citation>
      </ref>
      <ref id="cit0115">
        <label>115.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bisulli</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Vignatelli</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Provini</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Parasomnias and nocturnal frontal lobe epilepsy (NFLE): lights and shadows–controversial points in the differential diagnosis</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2011</year>;<volume>12</volume>(<issue>Suppl 2</issue>):<fpage>S27</fpage>–<lpage>32</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2011.10.008</pub-id><pub-id pub-id-type="pmid">22136895</pub-id></mixed-citation>
      </ref>
      <ref id="cit0116">
        <label>116.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Manni</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Terzaghi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Repetto</surname>
<given-names>A</given-names></string-name>. <article-title>The FLEP scale in diagnosing nocturnal frontal lobe epilepsy, NREM and REM parasomnias: data from a tertiary sleep and epilepsy unit</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2008</year>;<volume>49</volume>(<issue>9</issue>):<fpage>1581</fpage>–<lpage>1585</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01602.x</pub-id><pub-id pub-id-type="pmid">18410366</pub-id></mixed-citation>
      </ref>
      <ref id="cit0117">
        <label>117.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Foldvary-Schaefer</surname>
<given-names>N</given-names></string-name>, <string-name><surname>De Ocampo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mascha</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Accuracy of seizure detection using abbreviated EEG during polysomnography</article-title>. <source><italic toggle="yes">J Clin Neurophysiol</italic></source>. <year>2006</year>;<volume>23</volume>(<issue>1</issue>):<fpage>68</fpage>–<lpage>71</lpage>. doi:<pub-id pub-id-type="doi">10.1097/01.WNP.0000174544.86406.8D</pub-id><pub-id pub-id-type="pmid">16514353</pub-id></mixed-citation>
      </ref>
      <ref id="cit0118">
        <label>118.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jain</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dye</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kedia</surname>
<given-names>P</given-names></string-name>. <article-title>Value of combined video EEG and polysomnography in clinical management of children with epilepsy and daytime or nocturnal spells</article-title>. <source><italic toggle="yes">Seizure</italic></source>. <year>2019</year>;<volume>65</volume>:<fpage>1</fpage>–<lpage>5</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.seizure.2018.12.009</pub-id><pub-id pub-id-type="pmid">30590283</pub-id></mixed-citation>
      </ref>
      <ref id="cit0119">
        <label>119.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bubrick</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Yazdani</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pavlova</surname>
<given-names>M</given-names></string-name>. <article-title>Beyond standard polysomnography: advantages and indications for use of extended 10–20 EEG montage during laboratory sleep study evaluations</article-title>. <source><italic toggle="yes">Seizure</italic></source>. <year>2014</year>;<volume>23</volume>(<issue>9</issue>):<fpage>699</fpage>–<lpage>702</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.seizure.2014.05.007</pub-id><pub-id pub-id-type="pmid">24939522</pub-id></mixed-citation>
      </ref>
      <ref id="cit0120">
        <label>120.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Loddo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Sessagesimi</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mignani</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Specific motor patterns of arousal disorders in adults: a video-polysomnographic analysis of 184 episodes</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2018</year>;<volume>41</volume>:<fpage>102</fpage>–<lpage>109</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2017.08.019</pub-id><pub-id pub-id-type="pmid">29174185</pub-id></mixed-citation>
      </ref>
      <ref id="cit0121">
        <label>121.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Proserpio</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Loddo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Zubler</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Polysomnographic features differentiating disorder of arousals from sleep-related hypermotor epilepsy</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2019</year>;<volume>42</volume>:<fpage>12</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0122">
        <label>122.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tassinari</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rubboli</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gardella</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Central pattern generators for a common semiology in fronto-limbic seizures and in parasomnias. A neuroethologic approach</article-title>. <source><italic toggle="yes">Neurological Sci</italic></source>. <year>2005</year>;<volume>26</volume>(<issue>S3</issue>):<fpage>s225</fpage>–<lpage>32</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10072-005-0492-8</pub-id></mixed-citation>
      </ref>
      <ref id="cit0123">
        <label>123.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tassinari</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Cantalupo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Högl</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Neuroethological approach to frontolimbic epileptic seizures and parasomnias: the same central pattern generators for the same behaviours</article-title>. <source><italic toggle="yes">Rev Neurol (Paris)</italic></source>. <year>2009</year>;<volume>165</volume>(<issue>10</issue>):<fpage>762</fpage>–<lpage>768</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neurol.2009.08.002</pub-id><pub-id pub-id-type="pmid">19733874</pub-id></mixed-citation>
      </ref>
      <ref id="cit0124">
        <label>124.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Grillner</surname>
<given-names>S</given-names></string-name>. <article-title>Wallen P Central Pattern Generators for Locomotion, with Special Reference to Vertebrates</article-title>. <source><italic toggle="yes">Annu Rev Neurosci</italic></source>. <year>1985</year>;<volume>8</volume>(<issue>1</issue>):<fpage>233</fpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.ne.08.030185.001313</pub-id><pub-id pub-id-type="pmid">2984978</pub-id></mixed-citation>
      </ref>
      <ref id="cit0125">
        <label>125.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Howell</surname>
<given-names>M</given-names></string-name>. <article-title>Parasomnias: an updated review</article-title>. <source><italic toggle="yes">Neurotherapeutics</italic></source>. <year>2012</year>;<volume>9</volume>(<issue>4</issue>):<fpage>753</fpage>–<lpage>775</lpage>.<pub-id pub-id-type="pmid">22965264</pub-id></mixed-citation>
      </ref>
      <ref id="cit0126">
        <label>126.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Crompton</surname>
<given-names>D</given-names></string-name>. <article-title>Berkovic S The borderland of epilepsy: clinical and molecular features of phenomena that mimic epileptic seizures</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2009</year>;<volume>8</volume>(<issue>4</issue>):<fpage>370</fpage>–<lpage>381</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(09)70059-6</pub-id><pub-id pub-id-type="pmid">19296920</pub-id></mixed-citation>
      </ref>
      <ref id="cit0127">
        <label>127.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gaudreau</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Joncas</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zadra</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Dynamics of slow-wave activity during the NREM sleep of sleepwalkers and control subjects</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2000</year>;<volume>23</volume>(<issue>6</issue>):<fpage>755</fpage>–<lpage>760</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/23.6.1d</pub-id><pub-id pub-id-type="pmid">11007442</pub-id></mixed-citation>
      </ref>
      <ref id="cit0128">
        <label>128.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rodriguez</surname>
<given-names>C</given-names></string-name>. <article-title>Foldvary-Schaefer N. Clinical neurophysiology of NREM parasomnias</article-title>. <source><italic toggle="yes">Handb Clin Neurol</italic></source>. <year>2019</year>;<volume>161</volume>:<fpage>397</fpage>–<lpage>410</lpage>.<pub-id pub-id-type="pmid">31307616</pub-id></mixed-citation>
      </ref>
      <ref id="cit0129">
        <label>129.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nobili</surname>
<given-names>L</given-names></string-name>. <article-title>Nocturnal frontal lobe epilepsy and non-rapid eye movement sleep parasomnias: differences and similarities</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2007</year>;<volume>11</volume>(<issue>4</issue>):<fpage>251</fpage>–<lpage>254</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2007.03.009</pub-id><pub-id pub-id-type="pmid">17628315</pub-id></mixed-citation>
      </ref>
      <ref id="cit0130">
        <label>130.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Pincherle</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Proserpio</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Didato</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Epilepsy and NREM-parasomnia: a complex and reciprocal relationship</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2012</year>;<volume>13</volume>(<issue>4</issue>):<fpage>442</fpage>–<lpage>444</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2011.09.011</pub-id><pub-id pub-id-type="pmid">22285038</pub-id></mixed-citation>
      </ref>
      <ref id="cit0131">
        <label>131.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zanzmera</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Shukla</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Effect of successful epilepsy surgery on subjective and objective sleep parameters–a prospective study</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2013</year>;<volume>14</volume>(<issue>4</issue>):<fpage>333</fpage>–<lpage>338</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2012.11.017</pub-id><pub-id pub-id-type="pmid">23395512</pub-id></mixed-citation>
      </ref>
      <ref id="cit0132">
        <label>132.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Provini</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Plazzi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Montagna</surname>
<given-names>P</given-names></string-name>, et al. <article-title>The wide clinical spectrum of nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2000</year>;<volume>4</volume>(<issue>4</issue>):<fpage>375</fpage>–<lpage>386</lpage>. doi:<pub-id pub-id-type="doi">10.1053/smrv.2000.0109</pub-id><pub-id pub-id-type="pmid">12531176</pub-id></mixed-citation>
      </ref>
      <ref id="cit0133">
        <label>133.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Terzano</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Parrino</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Spaggiari</surname>
<given-names>M</given-names></string-name>. <article-title>The cyclic alternating pattern sequences in the dynamic organization of sleep</article-title>. <source><italic toggle="yes">Electroencephalogr Clin Neurophysiol</italic></source>. <year>1988</year>;<volume>69</volume>(<issue>5</issue>):<fpage>437</fpage>–<lpage>447</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0013-4694(88)90066-1</pub-id><pub-id pub-id-type="pmid">2451591</pub-id></mixed-citation>
      </ref>
      <ref id="cit0134">
        <label>134.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Terzano</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Parrino</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Sherieri</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern (CAP) in human sleep</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2001</year>;<volume>2</volume>(<issue>6</issue>):<fpage>537</fpage>–<lpage>553</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1389-9457(01)00149-6</pub-id><pub-id pub-id-type="pmid">14592270</pub-id></mixed-citation>
      </ref>
      <ref id="cit0135">
        <label>135.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Terzano</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Monge-Strauss</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mikol</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Cyclic alternating pattern as a provocative factor in nocturnal paroxysmal dystonia</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>1997</year>;<volume>38</volume>(<issue>9</issue>):<fpage>1015</fpage>–<lpage>1025</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1157.1997.tb01485.x</pub-id><pub-id pub-id-type="pmid">9579941</pub-id></mixed-citation>
      </ref>
      <ref id="cit0136">
        <label>136.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Picard</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Bruel</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Servent</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study</article-title>. <source><italic toggle="yes">Brain</italic></source>. <year>2006</year>;<volume>129</volume>:<fpage>2047</fpage>–<lpage>2060</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awl156</pub-id><pub-id pub-id-type="pmid">16815873</pub-id></mixed-citation>
      </ref>
      <ref id="cit0137">
        <label>137.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nauta</surname>
<given-names>W</given-names></string-name>. <article-title>Hippocampal projections and related neural pathways to the midbrain in the cat</article-title>. <source><italic toggle="yes">Brain</italic></source>. <year>1958</year>;<volume>81</volume>(<issue>3</issue>):<fpage>319</fpage>–<lpage>340</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/81.3.319</pub-id><pub-id pub-id-type="pmid">13596467</pub-id></mixed-citation>
      </ref>
      <ref id="cit0138">
        <label>138.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Halasz</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Kelemen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Szucs</surname>
<given-names>A</given-names></string-name>. <article-title>The role of NREM sleep micro-arousals in absence epilepsy and in nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Epilepsy Res</italic></source>. <year>2013</year>;<volume>107</volume>(<issue>1–2</issue>):<fpage>9</fpage>–<lpage>19</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2013.06.021</pub-id><pub-id pub-id-type="pmid">24050971</pub-id></mixed-citation>
      </ref>
      <ref id="cit0139">
        <label>139.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Licchetta</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Vignatelli</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zenesini</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Sleep-related hypermotor epilepsy: a prediction cohort study on sleep/awake patterns of seizures</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2019</year>;<volume>60</volume>(<issue>11</issue>):<fpage>e115</fpage>–<lpage>e120</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.16369</pub-id><pub-id pub-id-type="pmid">31612464</pub-id></mixed-citation>
      </ref>
      <ref id="cit0140">
        <label>140.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Di Resta</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ambrosi</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Curia</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Eur J Pharmacol</italic></source>. <year>2010</year>;<volume>643</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejphar.2010.05.063</pub-id><pub-id pub-id-type="pmid">20561518</pub-id></mixed-citation>
      </ref>
      <ref id="cit0141">
        <label>141.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kumar</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Solaiman</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mahakkanukrauh</surname>
<given-names>P</given-names></string-name>, et al. <article-title>Sleep Related Epilepsy and Pharmacotherapy: an Insight</article-title>. <source><italic toggle="yes">Front Pharmacol</italic></source>. <year>2018</year>;<volume>9</volume>:<fpage>1088</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphar.2018.01088</pub-id><pub-id pub-id-type="pmid">30319421</pub-id></mixed-citation>
      </ref>
      <ref id="cit0142">
        <label>142.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gambardella</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Annesi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>De Fusco</surname>
<given-names>M</given-names></string-name>, et al. <article-title>A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chromosome 1</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2000</year>;<volume>55</volume>(<issue>10</issue>):<fpage>1467</fpage>–<lpage>1471</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.55.10.1467</pub-id><pub-id pub-id-type="pmid">11094099</pub-id></mixed-citation>
      </ref>
      <ref id="cit0143">
        <label>143.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Oldani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Manconi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zucconi</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Topiramate treatment for nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Seizure</italic></source>. <year>2006</year>;<volume>15</volume>(<issue>8</issue>):<fpage>649</fpage>–<lpage>652</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.seizure.2006.07.002</pub-id><pub-id pub-id-type="pmid">16973383</pub-id></mixed-citation>
      </ref>
      <ref id="cit0144">
        <label>144.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Romigi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Marciani</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Placidi</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Oxcarbazepine in nocturnal frontal-lobe epilepsy: a further interesting report</article-title>. <source><italic toggle="yes">Pediatr Neurol</italic></source>. <year>2008</year>;<volume>39</volume>(<issue>4</issue>):<fpage>298</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2008.07.015</pub-id><pub-id pub-id-type="pmid">18805375</pub-id></mixed-citation>
      </ref>
      <ref id="cit0145">
        <label>145.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Raju</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Sarco</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Poduri</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Oxcarbazepine in children with nocturnal frontal-lobe epilepsy</article-title>. <source><italic toggle="yes">Pediatr Neurol</italic></source>. <year>2007</year>;<volume>37</volume>(<issue>5</issue>):<fpage>345</fpage>–<lpage>349</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2007.06.013</pub-id><pub-id pub-id-type="pmid">17950420</pub-id></mixed-citation>
      </ref>
      <ref id="cit0146">
        <label>146.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mullen</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Carney</surname>
<given-names>PW</given-names></string-name>, <string-name><surname>Roten</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Precision therapy for epilepsy due to KCNT1 mutations: a randomized trial of oral quinidine</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2018</year>;<volume>90</volume>(<issue>1</issue>):<fpage>e67</fpage>–<lpage>e72</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000004769</pub-id><pub-id pub-id-type="pmid">29196578</pub-id></mixed-citation>
      </ref>
      <ref id="cit0147">
        <label>147.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Samarasekera</surname>
<given-names>SR</given-names></string-name>. <article-title>A case series of lacosamide as adjunctive therapy in refractory sleep-related hypermotor epilepsy (previously nocturnal frontal lobe epilepsy)</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2018</year>;<volume>27</volume>(<issue>5</issue>):<fpage>e12669</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.12669</pub-id><pub-id pub-id-type="pmid">29479765</pub-id></mixed-citation>
      </ref>
      <ref id="cit0148">
        <label>148.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Puligheddu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Melis</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Pillolla</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy</article-title>. <source><italic toggle="yes">Epilepsia</italic></source>. <year>2017</year>;<volume>58</volume>(<issue>10</issue>):<fpage>1762</fpage>–<lpage>1770</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.13863</pub-id><pub-id pub-id-type="pmid">28766701</pub-id></mixed-citation>
      </ref>
      <ref id="cit0149">
        <label>149.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Derry</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Harvey</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>MC</given-names></string-name>, et al. <article-title>NREM arousal parasomnias and their distinction from nocturnal frontal lobe epilepsy: a video EEG analysis</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2009</year>;<volume>32</volume>(<issue>12</issue>):<fpage>1637</fpage>–<lpage>1644</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/32.12.1637</pub-id><pub-id pub-id-type="pmid">20041600</pub-id></mixed-citation>
      </ref>
      <ref id="cit0150">
        <label>150.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tinuper</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Provini</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Bisulli</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2007</year>;<volume>11</volume>(<issue>4</issue>):<fpage>255</fpage>–<lpage>267</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2007.01.001</pub-id><pub-id pub-id-type="pmid">17379548</pub-id></mixed-citation>
      </ref>
      <ref id="cit0151">
        <label>151.</label>
        <mixed-citation publication-type="journal">Tinuper P, Bisulli F. From nocturnal frontal lobe epilepsy to Sleep-Related Hypermotor Epilepsy: A 35-year diagnostic challenge. <italic toggle="yes">Seizure</italic>. <year>2017</year>;44:87–92. doi:<pub-id pub-id-type="doi">10.1016/j.seizure.2016.11.023</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
